The QualityStocks Daily Tuesday, July 2nd, 2024

Today's Top 3 Investment Newsletters

QualityStocks(OPTT) $0.5140 +86.10%

360 Wall Street(RDZN) $2.9500 +82.10%

BioMedWire(ANVS) $9.2800 +76.09%

The QualityStocks Daily Stock List

Ocean Power Technologies (OPTT)

Lebed.biz, QualityStocks, SmarTrend Newsletters, InvestorPlace, StreetInsider, MarketClub Analysis, StockMarketWatch, BUYINS.NET, MarketBeat, Jason Bond, TraderPower, Wall Street Grand, TheStockAdvisor, OTCtipReporter, PennyStockScholar, The Street, Schaeffer's, National Inflation Association, Alternative Energy, Bull in Advantage, FeedBlitz, GreatStockPix, The Online Investor, Stock Stars, Money Morning, Stock Market Watch, StockOodles, The Best Newsletters, TradersPro, Investing Futures, Investor Ideas, Promotion Stock Secrets, Dynamic Wealth Report, DreamTeamNetwork, Cabot Wealth, Barchart, AnotherWinningTrade, Market FN, Equities.com, Stock Beast, Wall Street Greek, Trading Concepts, Trades Of The Day, TopStockAnalysts, TopPennyStockMovers, StocksEarning, PennyToBuck, Stock Research Newsletter, Marketbeat.com, SmallCapVoice, Real Pennies, Wall Street Mover, Premium Stock Alerts, OTCPicks, MarketDeal and StockEarnings reported earlier on Ocean Power Technologies (OPTT), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Ocean Power Technologies Inc. (NASDAQ: OPTT) (FRA: RUOC) is focused on the development and commercialization of proprietary systems which generate electricity from the renewable energy of ocean waves in Asia, Europe, South and North America.

Ocean Power Technologies is based in Monroe Township, New Jersey and was incorporated on April 19, 1984 by George W. Taylor. The firm serves agencies as well as private and public entities that need remote offshore power. The majority of the firm’s revenue is generated from North America.

Ocean Power Technologies operates in the following geographical segments: Australia, Asia, Europe and North America. The firm is focused on developing its PowerBuoy product line, which is based on ocean-going modular buoys, for use in autonomous power applications. The PowerBuoy system integrates patented technologies in energy conversion, electronic, hydrodynamics and computer control systems to obtain natural energy from the waves of the ocean.

Ocean Power Technologies offers marine installation services, integration services and payloads as well as various hybrid PowerBuoy products such as subsea battery systems. Additionally, the firm also provides real-time data communications and electric power for subsea applications and remote offshore markets such as communications, science and research, defense and security and offshore oil and gas.

As of 2021, Ocean Power Technologies had acquired 3Dent Technology, an energy engineering firm, which will broaden Ocean Power’s ability to offer comprehensive solutions to consumers, which will accelerate the growth of both firms and also expand and solidify Ocean Power’s position as an offshore energy solution provider.

Ocean Power Technologies (OPTT), closed Tuesday's trading session at $0.514, up 86.097%, on 616,465,098 volume. The average volume for the last 3 months is 17,598 and the stock's 52-week low/high is $0.12/$0.769.

Oliveda International (OLVI)

QualityStocks, StocksEarning, StockHideout, Stock Guru, ProTrader, Stock Commander, KingPennyStocks, Penny Stock 101, Penny Stock General, PennyStockLocks, BullFreak, Small Cap Firm, Winston Small Cap, StockRockandRoll, StockRunway, StockTradingNetwork and Shiznit Stocks reported earlier on Oliveda International (OLVI), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Oliveda International Inc. (OTC: OLVI) is a leading global natural cosmetic company focused on manufacturing and distributing cosmetic and holistic products built around the pure essence of the olive tree and its oils.

The firm has its headquarters in Santa Monica, California and was incorporated in 1987, on May 5th by Thomas Lommel, a German real estate investor. It operates as part of the household and personal products industry, under the consumer defensive sector. The firm serves consumers around the globe.

The company is the largest investor in eco-certified mountain olive trees as well as the largest conservationist in Arroyomolinosde Leó, Spain. Its wholly-owned second-tier subsidiary, Oliveda DeutschlandGmbH, operates flagship stores, Olive Tree Pharmacy, in Dusseldorf and Berlin with plans to open new locations in Seoul, Los Angeles and Taipei. Overall, the company believes that it will be able to operate a total of 60 of its own flagship stores worldwide and increase the retail store network worldwide to 1,200 over the next 5 years.

The enterprise’s product lines include serums, facial washes, eye care products, and facial oils. Its body line of products includes body oils, washes, hand and foot care products along with other bathing products. Its holistic products include products based upon the wholesome essence of extra virgin olive oil, with mouth drawing oils, Orac and CamuCamu concentrate, Hydroxytyrosol Molecule, Tea Olive Matcha, and other products that have been shown to help the body perform more efficiently, and hair products include both shampoo and conditioners which are foremost in the industry.

The company recently announced new products in its waterless beauty lines, a move that may help better meet consumer needs while also bringing in additional revenues into the company.

Oliveda International (OLVI), closed Tuesday's trading session at $10.4, up 25.3012%, on 127,535 volume. The average volume for the last 3 months is 100,216 and the stock's 52-week low/high is $0.035/$11.38.

Benitec Biopharma (BNTC)

QualityStocks, MarketBeat, MarketClub Analysis, StockMarketWatch, StockEarnings, TraderPower, Jason Bond, Profitable Trader Authority, BUYINS.NET, InvestorsUnderground, Money Morning, AllPennyStocks, PennyStockProphet, Trades Of The Day, Promotion Stock Secrets, Schaeffer's, Top Pros' Top Picks and OTCtipReporter reported earlier on Benitec Biopharma (BNTC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Benitec Biopharma Inc. (NASDAQ: BNTC) (FRA: BJ93) is a development-stage biotechnology firm that is engaged in developing new genetic therapies.

The firm has its headquarters in Hayward, California and was incorporated in 1995, on April 7th. Prior to its name change, the firm was known as Benitec Biopharma Ltd.

It is currently designing a therapeutic technology platform that has combined gene therapy with RNA (ribonucleic acid), to offer long-lasting and sustained silencing of genes that cause various ailments, from one administration. The technology, which has been dubbed ddRNAi, or DNA (Deoxyribonucleic acid¬)-directed RNA interference is being used to develop drug formulations for life-threatening and chronic human ailment areas, which include infectious ailments and orphan diseases. This technology, which is available from the company under different license options, is safer to use and easier to deliver. This is in addition to being more efficient and targeted. The ddRNAi is protected by more than forty global patents and possesses the ability to silence genes associated with thousands of ailments.

The company’s product pipeline is made up of partnered drug and in-house development programs, which are based off of the ddRNAi. Their candidates include an adeno-associated virus termed BB-301, which has been indicated for the treatment of chronic hepatitis B virus infection and oculopharyngeal muscular dystrophy (OPMD).

An interim analysis conducted demonstrated that the firm’s BB-301 candidate was biologically significant and very consistent, while also showing a 111 and 248 fold-improvement in transduction of pharyngeal muscles. Clinical trial success may boost the firm’s growth as well as attract investments into the firm.

Benitec Biopharma (BNTC), closed Tuesday's trading session at $8.7, up 19.7687%, on 58,626 volume. The average volume for the last 3 months is 1.834M and the stock's 52-week low/high is $1.86/$10.70.

CareCloud Inc. (CCLD)

QualityStocks, Prism MarketView, InvestorPlace and MarketClub Analysis reported earlier on CareCloud Inc. (CCLD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

CareCloud, Inc. (Nasdaq: CCLD, CCLDP, CCLDO) is healthcare information technology firm that is engaged in the provision of a suite of cloud-based solutions and associated business services to hospitals and healthcare providers.

The firm has its headquarters in Somerset, New Jersey and was incorporated in 1999 by Mahmud Haq. Prior to its name change in March 2021, the firm was known as MTBC Inc. It operates as part of the health information services industry, under the healthcare sector. The firm serves consumers in the United States.

The company’s mission is to revolutionize the healthcare experience through on-demand services and software which will help modernize workflow in physician practices. It operates through the Practice Management and Healthcare IT segments. The practice management segment provides medical practices, as well as financial advisory, bill-paying, management and telemedicine services. On the other hand, the Healthcare IT division provides a proprietary web-based suite of services such as mobile health applications, revenue cycle management services, certified electronic health records solutions and practice management applications.

The enterprise’s SaaS (Software-as-a-Service) platform includes complementary software tools and business services for health systems and medical groups. It serves physician assistants, nurse practitioners, nurses, physicians and other clinicians that render bills for their services.

The firm recently expanded its executive leadership team with a number of strategic hires and important promotions. This move will support its growth plans as it improves its technology-enabled services and expands its global market share, which will bring in considerable investments and revenues.

CareCloud Inc. (CCLD), closed Tuesday's trading session at $2.29, up 17.4359%, on 192,032 volume. The average volume for the last 3 months is 97,861 and the stock's 52-week low/high is $0.68/$3.80.

CytoSorbents Corp. (CTSO)

Wall Street Resources, QualityStocks, StockMarketWatch, MarketBeat, Marketbeat.com, MarketClub Analysis, PennyStocks24, SmallCapVoice, StreetInsider, The Street, TradersPro, MoneyTV, BUYINS.NET, AllPennyStocks, MicroCap Gems, Alliance Advisors, PennyOmega, Streetwise Reports, Tiny Gems, Barchart, BestOtc, BullRally, The Stock Dork, Buzz Stocks, CoolPennyStocks, CRWEFinance, CRWEPicks, CRWEWallStreet, DrStockPick, FeedBlitz, PennyStockProphet, HotOTC, SECFilings.com News, Stockpalooza, Stockoutlaws, StockOnion, StockHotTips, Penny Pick Finders, Pennybuster, Stock Rich, Stock Guru, Wise Alerts, PennyToBuck, PennyTrader Publisher, Planet Penny Stocks, SecretStockPromo and FreeRealTime reported earlier on CytoSorbents Corp. (CTSO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

CytoSorbents Corp. (NASDAQ: CTSO) (FRA: HQE1) is a critical care focused immunotherapy firm that is focused on researching, developing and commercializing medical devices.

The firm has its headquarters in Monmouth Junction, New Jersey and was incorporated in 2002, on April 25th by Joseph Rubin. Prior to its name change in May 2010, the firm was known as MedaSorb Technologies Corp. It operates as part of the medical equipment and supplies manufacturing industry. The firm has five companies in its corporate family and serves consumers around the globe.

The company uses its blood purification technology platform which incorporates an adsorbent and porous polymer technology to develop its devices which have applications in various fields. It has a broad patent application portfolio pending, multiple patents issued globally and about 19 issued patents.

The enterprise’s product pipeline comprises of an extracorporeal cytokine filter dubbed CytoSorb, developed for adjunctive therapy in the treatment of sepsis. It also develops K+ontrol to treat severe hyperkalemia in individuals with life-threatening conditions; a blood purification tech platform known as HemoDefend, which decreases contaminants in the blood supply; a device known as CytoSorb-XL, for adjunctive therapy in the treatment of critical ailments like sepsis; and a device for adjunctive therapy known as VetResQ, which has also been developed to treat pancreatitis, sepsis and other severe ailments in animals.

The company recently announced its latest financial results for 2021, with its CEO noting that they were focused on diversifying their revenue sources, launching new clinical applications and maximizing the existing applications and expanding its direct sales territories.

CytoSorbents Corp. (CTSO), closed Tuesday's trading session at $0.8218, up 17.4%, on 379,186 volume. The average volume for the last 3 months is 120,375 and the stock's 52-week low/high is $0.70/$4.29.

Passage Bio (PASG)

StreetInsider, MarketBeat, QualityStocks, Zacks, InsiderTrades and FreeRealTime reported earlier on Passage Bio (PASG), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Passage Bio Inc. (NASDAQ: PASG) is a genetics medicine firm that is focused on the development of transformative therapies for illnesses affecting the central nervous system.

The firm has its headquarters in Philadelphia, Pennsylvania and was incorporated in July 2017 by James M. Wilson, Aditya Kohli, David A. Socks, Tadataka Yamada and Stephen P. Squinto. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers in the United States, with a focus on consumers in the state of Pennsylvania.

The company is party to a collaboration agreement as well as a clinical supply and development services agreement with Catalent Maryland Inc. It is also party to a strategic collaboration with the Trustees of the Gene Therapy Program at the University of Pennsylvania.

The enterprise’s product pipeline includes PBCM06, which has been developed to treat Charcot-Marie-Tooth Type 2A; PBAL05 for treating amyotrophic lateral sclerosis; and PBML04 for treating metachromatic leukodystrophy. It also develops PBFT02, which uses AAV1 capsids to transport a gene encoding progranulin to the brain, to treat FTD-GRN (fronto-temporal dementia caused by a deficiency of progranulin). This is in addition to developing PBGM01, which uses AAVhu68 capsids to ferry beta-galactosidase; a gene encoding lysosomal acid, to the brain and peripheral tissues. Furthermore, it develops PBKR03 for the treatment of Krabbe disease.

The firm is currently focused on advancing its research and development programs, in partnership with the Gene Therapy Program. This move will open the firm up to new opportunities, which will bolster its growth significantly and benefit its shareholders.

Passage Bio (PASG), closed Tuesday's trading session at $0.9996, up 12.9492%, on 160,810 volume. The average volume for the last 3 months is 78,850 and the stock's 52-week low/high is $0.5751/$1.79.

Genasys Inc. (GNSS)

QualityStocks, MarketBeat, InvestorPlace, InsiderTrades and FreeRealTime reported earlier on Genasys Inc. (GNSS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Genasys Inc. (NASDAQ: GNSS) (FRA: G66) is a firm that is engaged in the provision of essential communications software and hardware solutions.

The firm has its headquarters in San Diego, California. Prior to its name change in 2010, the firm was known as LRAD Corp. It operates as part of the technology sector. The firm serves consumers around the world.

The company operates through the software and hardware segments. It is focused on the development of critical communication solutions and provides a platform which offers geo-targeted, multi-modal cellphone alerts with vocal clarity. Its principal markets are Asia, the Middle East, Europe, North and South America.

The enterprise’s offerings include a product line that’s software-based dubbed Genasys Emergency Management; and an emergency response solution known as Integrated Mass Notification Systems, which unite Genasys’ speaker system hardware with GEM software. It also provides a software application dubbed the National Emergency Warning Systems, which sends emergency alerts to the public via different mobile carriers; and GEM software to social media, emails, television, voice calls, desktop alerts, text messages and panic buttons. The enterprise also offers long range acoustic devices, including acoustic hailing devices which are used to project audible voice messages and sirens. It sells its products to commercial firms, end-users, militaries and governments.

The company recently released its latest financial results, which show increases in its year-over-year revenue for 2022. It is currently focused on growing its SaaS (Software-as-a-service) business which will encourage more investments into the company.

Genasys Inc. (GNSS), closed Tuesday's trading session at $2.56, up 12.7753%, on 182,740 volume. The average volume for the last 3 months is 1.858M and the stock's 52-week low/high is $1.51/$3.9199.

Momo Inc. (MOMO)

StocksEarning, QualityStocks, MarketClub Analysis, InvestorPlace, StockEarnings, Schaeffer's, Marketbeat, Market Intelligence Center Alert, Zacks, The Street, Trades Of The Day, Kiplinger Today, Daily Trade Alert, StreetInsider, The Street Report, Marketbeat.com, BUYINS.NET, The Online Investor, FreeRealTime, INO.com Market Report, ChineseWire, Trading Concepts, Louis Navellier, TradersPro, Wealth Insider Alert, StreetAuthority Daily, TopStockAnalysts, Money Morning, Investopedia, DividendStocks, Daily Wealth, PennyDoctor, TipRanks, Greenbackers, StockMarketWatch, StocksImpossible, Street Insider, OTCBB Journal, Early Bird, First Penny Picks, ChartAdvisor, Barchart, CrashTrade, Investing Signal, InvestmentHouse, Jason Bond, AskSlapper, Orbit Stocks, Profit Confidential, Promotion Stock Secrets, Short Term Wealth, Terry's Tips, The Best Newsletters, The Stock Dork and One Hot Stock reported earlier on Momo Inc. (MOMO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The entertainment industry’s push to increase sustainability in unscripted television took a significant step forward after 30 production studios and companies lent their support to the cause. Reality of Change founder Cyle Zezo and Ellis Watamanuk, senior director at Rare’s Entertainment Lab, first launched the formal initiative to increase sustainability in unscripted TV two months ago and held the first committee meeting in late May.

After spending weeks seeking support within the entertainment industry, nonprofit organization RARE and ecoentertainment company Reality of Change rounded up 30 production companies and studios to help build an advisory committee to begin coming up with climate-change solutions in the entertainment industry. Some of the companies involved in working on the advisory committee include Chip and Joanna Gaines’ Blind Nil, Scout Productions and MGM Alternative.

Watamanuk and Zezo lead several committee meetings throughout the year to start laying down a plan of action to help unscripted television producers set achievable climate goals and achieve tangible results as they strive to achieve sustainability behind and in front of the camera. Representatives from major production houses such as the Intellectual Property Corporation at Sony Pictures Television as well as successful indie producers such as Scout Productions will be involved in crafting solutions to address sustainability in unscripted TV.

According to Watamanuk, the advisory committee has several decades’ worth of experience, and its members have produced some of the world’s most popular unscripted TV. Consequently, the Entertainment Lab senior director noted that the committee was well equipped to blaze a path for the industry’s sustainability journey. He observed that the participation and active engagement the committee members bring will help to lay a robust foundation and create a clear road map for the unscripted TV industry to make real and tangible progress.

Watamanuk added that the task force’s goal will be to focus on what the unscripted television segment can achieve in the near future while also identifying the resources and data the sector can use to achieve its environmental goals in the long-term before issuing a report once the process is complete.

Zezo added that the group recruited unscripted TV creators across the entire entertainment industry, choosing creators from the largest producers to the smallest indie houses to ensure the advisory committee produces diverse solutions and ideas to the industry’s climate-change problems. The unscripted television industry was receptive to the initiative’s call for action, Zezo said, and is eager to help push sustainability in the sector.

Companies with interests in the TV and radio production industry, such as Momo Inc. (NASDAQ: MOMO), are embracing a variety of measures to take leadership in driving change for the better on matters of sustainability, accountability and fairness.

Momo Inc. (MOMO), closed Tuesday's trading session at $6.06, off by 1.1419%, on 715,809 volume. The average volume for the last 3 months is 807,269 and the stock's 52-week low/high is $4.79/$11.12.

Curaleaf Holdings Inc. (CURLF)

InvestorPlace, QualityStocks, Kiplinger Today, MarketBeat, Cabot Wealth, Daily Trade Alert, Top Pros' Top Picks, The Online Investor, MarketClub Analysis, Profit Trends, Wealth Insider Alert, StreetInsider, Early Bird, Trading For Keeps, Trades Of The Day, The Street, Prism MarketView, TradersPro, Zacks, Schaeffer's, Investment U, StreetAuthority Daily, wyatt research newsletter, Daily Profit, CFN Media Group, CannabisNewsWire and Wyatt Investment Research reported earlier on Curaleaf Holdings Inc. (CURLF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

New research has determined that trade data disparities are impeding hemp trade globally and withholding environmental and economic benefits for developing countries. The research, carried out by the United Nations Conference on Trade and Development (UNCTAD), involved all countries around the globe.

In the report, Marco Fugazza wrote that a systematic approach to help measure global trade in hemp products would close the gap between national and global classifications for hemp outputs. Fugazza, a UN economist, explained that this inconsistency hindered policymakers’ ability to come up with strategies to harness industrial hemp’s economic potential and also impacted understanding of global trade dynamics. He added that an international effort to measure hemp trade flows could especially benefit nations in Asia and South America, as their hemp industry was burgeoning.

According to the report, combined national customs data showed that in 2022, the export value of hemp products added up to about $213 million. This differs significantly from data released by the UN Comtrade database, which recorded trade valued at $46 million in the same year. UN commodity trade statistics, or Comtrade in short, utilizes global classifications for hemp products.

The disparity is mainly because Comtrade’s figures only include semiprocessed and raw hemp yard and fiber, excluding food manufactured from hemp grain and finished products. National export figures estimate total trade of the excluded products adds up to $112 million.

In a press release distributed when it introduced the study, UNCTAD explained that the true scale of the international hemp market was underestimated because the global harmonized classification system didn’t include a significant portion of items traded. The report also highlighted that while national hemp-product classifications were more extensive, their coverage had some hindrances. For instance, they didn’t account for outputs for hemp with high potential for sustainability such as hemp biochar and hurd for hempcrete. Hemp biochar contributes to sustainable agriculture by absorbing CO2 and improving the health of soil. On the other hand, hempcrete is a nature-friendly material used for building.

Currently, Canada is the leading exporter of hemp grain globally. With regard to exports of semiprocessed and raw hemp products, the Netherlands, Spain and France dominate the market. The study also determined that China was a huge player in the market for hemp yarn. In addition, the study found that about 60 nations exported hemp between 2019 and 2020, with one-third being developing countries. Overall, nations in the European Union, China and Canada dominate hemp exports globally.

The enhanced tracking being advocated for by the UN could expose market participants in diverse regions around the world to business opportunities with established enterprises such as Curaleaf Holdings Inc. (CSE: CURA) (OTCQX: CURLF) that may be looking to diversify their product line-ups, especially in the area of medical products.

Curaleaf Holdings Inc. (CURLF), closed Tuesday's trading session at $3.78, off by 2.5773%, on 320,189 volume. The average volume for the last 3 months is 1.517M and the stock's 52-week low/high is $2.51/$6.40.

Mind Medicine Inc. (MNMD)

QualityStocks, InvestorPlace, Schaeffer's, PsychedelicNewsWire, MarketBeat, TradersPro, The Wealth Report, The Street, The Stock Dork, MarketClub Analysis, Daily Trade Alert, Wealth Daily and Trades Of The Day reported earlier on Mind Medicine Inc. (MNMD), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

The University of Colorado Denver recently launched the CU Denver Center for Psychedelic Research. This center is focused on improving the quality of life of individuals by conducting research on the potential benefits psychedelics may possess in the treatment of various mental, neurological, emotional and other health conditions as well as their possible use in the management of chronic, debilitating illnesses such as cancer.

Professor Jim Grigsby, executive director and the center’s chief science officer, revealed that a national study was going on and the center was also planning a number of other studies. Grigsby, who teaches psychology at CU Denver, added that there was so much promise in this field of research and center officials were in talks with potential collaborators in the state.

The new center, located in the downtown campus on CU Denver, will conduct research on the impact of the use of psychedelics on the society as well as the economy. Studies in these areas will include research on how the new law in the state shall be applied, as well as the public health and ethical implications. Personnel at the center are also tasked with developing a structured educational curriculum to train individuals who would like to administer psychedelics in clinical settings.

In addition, the center plans to conduct research on the therapeutic mechanisms and effectiveness of these substances as therapies for various conditions, in collaboration with researchers on the CU Boulder and Anschutz campuses.

Scientists started investigating classic psychedelics for therapeutic use decades ago. However, this changed in the 1970s when the war on drugs ground research to a halt.

This has changed in the recent past, with the federal government even going as far as to provide funding for research. Additionally, some jurisdictions are considering enacting or have already enacted legislations decriminalizing psychedelic substances.

In 2022, voters in the state of Colorado approved Proposition 122, which decriminalized some fungal and plant-based psychedelic drugs. The measure also directed that the state establish regulations governing the use of these substances in controlled clinical settings to individuals aged 21 years and older. The protocols are set to go into effect this year.

Grigsby is also a coprincipal researcher of one of the country’s biggest studies on psilocybin’s therapeutic use in patients on end-of-life care. In his statement, he explained that preliminary studies suggested that psychedelics could enhance or induce neurogenesis and neural plasticity in some parts of the brain.

Psychedelics are said to have potent anti-inflammatory effects, which may make them effective as treatments for neurological conditions, including some neurodegenerative illnesses. Several companies, including Mind Medicine Inc. (NASDAQ: MNMD) (NEO: MMED) (DE: MMQ), are racing to study how this therapeutic potential can be harnessed to take the management of various diseases to a whole new level.

Mind Medicine Inc. (MNMD), closed Tuesday's trading session at $6.96, off by 1.5559%, on 744,320 volume. The average volume for the last 3 months is 510,916 and the stock's 52-week low/high is $2.41/$12.22.

Verano Holdings Corp. (VRNOF)

QualityStocks, MarketBeat, InvestorPlace, CannabisNewsWire, The Street, Earnings360, Early Bird and Cabot Wealth reported earlier on Verano Holdings Corp. (VRNOF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

A recent study has revealed that medical cannabis can offer numerous therapeutic benefits for older adults, positively impacting their mood, sleep, health and well-being. The study observed significant reductions in both pain interference and severity in older adults who use cannabis to manage chronic pain.

Published in the “Drugs and Aging Journal,” the study addresses the limited high-quality studies on marijuana use among older adults. Typically, clinical trials exclude participants older than 65 years of age, even as this demographic increasingly turns to medical cannabis for relief.

The research, which was carried out by a group from Drug Science and the Center for Neuropsychopharmacology at Imperial College London, examined information from the T21 project, a sizable cannabis observational study that was started in the United Kingdom (UK) in 2020.

Since 2018, marijuana-based medical products (CBMPs) have been legally prescribed in the UK. However, access through the National Health Service is limited, with most prescriptions coming from the private market.

The study measured patient outcomes through self-reported overall health, quality of life, sleep and mood metrics. Findings showed steady improvements in all these areas from the start of treatment to a three-month follow-up. Older adults who continued using CBMPs reported significant enhancements in their well-being and overall health.

Further, the study noted that while older patients’ improvements in mood and quality of life were not as significant as those of younger patients (those below 65 years), the advantages were still significant. Improvements in general health and sleep were similar across all age groups.

The researchers emphasized the importance of their findings in filling a gap in the current understanding of medical marijuana use among older adults. They highlighted a nationwide study by the Center for Medical Marijuana that failed to differentiate older persons over age 55, and the UK’s National Statistics Office, which does not gather particular information on marijuana usage by adults over the age of 59. Additionally, they noted that most data does not distinguish between recreational and medical use.

The study also identified distinctions between older and younger patients. Older patients were more likely to be female, report chronic pain as their major condition and be on multiple prescribed medications. They were also less likely to have used cannabis before and to use it daily before starting treatment. When prescribed, older patients were more likely to receive CBD-infused oils and less likely to receive cannabis flower with high-THC potency.

The study concludes that the improvements, even if slightly lower in quality of life and mood for older adults, are significant and add to the limited knowledge about medical marijuana in this age group.

As more becomes known about the specific ways in which different groups of patients, such as seniors, can benefit from medical marijuana products, businesses such as Verano Holdings Corp. (CSE: VRNO) (OTCQX: VRNOF) could see their clientele growing faster in the years to come.

Verano Holdings Corp. (VRNOF), closed Tuesday's trading session at $3.544293, off by 2.8961%, on 231,918 volume. The average volume for the last 3 months is 8.774M and the stock's 52-week low/high is $2.53/$7.08.

Pinterest Inc. (PINS)

Schaeffer's, InvestorPlace, Kiplinger Today, MarketClub Analysis, StockEarnings, The Street, MarketBeat, Zacks, StocksEarning, Trades Of The Day, Daily Trade Alert, INO Market Report, The Online Investor, Early Bird, Investopedia, Top Pros' Top Picks, Cabot Wealth, StreetInsider, QualityStocks, Wealth Insider Alert, FreeRealTime, TradersPro, TipRanks, CNBC Breaking News, StreetAuthority Daily, StockMarketWatch, BUYINS.NET, InvestmentHouse, InvestorsUnderground, AllPennyStocks, Hit and Run Candle Sticks, InsiderTrades, Investing Daily, Investment House, 360 Wall Street, Market Intelligence Center Alert, Smart Investing Society, Smart money trading, Trading Tips and Louis Navellier reported earlier on Pinterest Inc. (PINS), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Pinterest (NYSE: PINS), a popular social media platform known for its visual discovery engine, is taking a significant step to attract a younger demographic by introducing a new feature called “board sharing.” This feature allows users to share videos of their favorite boards to other social platforms, targeting Generation Z—the youngest and most digitally engaged generation. This move is part of Pinterest’s broader strategy to expand its user base and enhance user engagement by introducing innovative features that resonate with the preferences of younger audiences.

The introduction of the “board sharing” feature comes at a time when Pinterest’s stock performance is showing positive signs. Trading on the NYSE, Pinterest’s stock price recently reached $43.155, marking a slight increase of 0.17% with a change of $0.075. This indicates a growing investor confidence in Pinterest’s strategic initiatives and its potential for future growth. The stock has experienced fluctuations over the past year, with prices ranging from a low of $23.59 to a high of $45.185, reflecting the volatile nature of the tech market and investor sentiment towards social media companies.

Pinterest’s market capitalization, standing at approximately $29.48 billion, underscores the company’s significant presence in the social media landscape. With a trading volume of 2.19 million shares, it’s clear that Pinterest is a key player among investors and traders, closely watched for its growth potential and innovative approaches to capturing the attention of a broader audience, especially the younger generation.

By focusing on features that cater to Generation Z, Pinterest is not only looking to boost its user engagement but also to solidify its position in the competitive social media market. The “board sharing” feature represents a strategic move to leverage video content, which is highly popular among younger users, to drive more traffic to the platform and encourage active participation. This approach aligns with the growing trend of integrating video content across social platforms to enhance user experience and engagement.

Overall, Pinterest’s initiative to court Generation Z with the “board sharing” feature, as highlighted by PYMNTS, reflects a forward-thinking strategy aimed at tapping into the preferences of the digital-savvy younger generation. With its recent stock performance showing positive momentum, Pinterest is well-positioned to continue its growth trajectory and strengthen its appeal among a wider audience, leveraging innovative features to stay ahead in the competitive social media space.

To view the company’s most recent earnings release, visit https://ibn.fm/c7EoO

About Pinterest Inc.

Pinterest Inc. is a visual discovery engine that helps people find inspiration for their lives. With billions of Pins on our platform, we help people discover and do what they love. Whether planning a new project or looking for an idea, Pinterest allows users to explore a wide range of interests and hobbies, from cooking and fashion to travel and home decor. Pinterest’s mission is to bring everyone the inspiration to create a life they love. Launched in 2010, Pinterest is headquartered in San Francisco, California, and is available in more than 30 languages globally.

Pinterest Inc. (PINS), closed Tuesday's trading session at $43.26, up 0.4178273%, on 5,424,680 volume. The average volume for the last 3 months is 1.184M and the stock's 52-week low/high is $23.59/$45.185.

The QualityStocks Company Corner

Annovis Bio Inc. (NYSE: ANVS)

The QualityStocks Daily Newsletter would like to spotlight Nightfood Holdings Inc. (NYSE: ANVS).

Annovis Bio (NYSE: ANVS), a late-stage, clinical-drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer's disease ("AD") and Parkinson's disease ("PD"), is reporting new data from its phase 3 PD study. According to the report, study findings indicate that buntanetap, the company's proprietary drug candidate, is safe and effective in improving motor and nonmotor activities and improving cognitive functions in patients with early Parkinson's disease. Specifically, buntanetap stopped cognitive decline in all enrolled patients and improved cognition in patients with mild dementia, improved motor and nonmotor PD-related functions in patients with a diagnosis of more than three years, and improved motor and nonmotor PD-related functions in patients with postural instability and gait difficulty ("PIGD"). Buntanetap targets neurodegeneration by hindering the formation of multiple neurotoxic proteins, including amyloid beta, tau, alpha-synuclein and TDP43. It also works to reverse neurodegeneration in AD, PD and other neurodegenerative diseases, restoring brain function and improving a patient's quality of life. The company has scheduled a webcast today to discuss the study findings in more detail. The webcast will begin at 4:30 p.m. ET. "We are very pleased to see improvements in many of our patients over such a short course of treatment," said Annovis Bio president and CEO Maria Maccecchini, PhD, in the press release. "These compelling data reinforce our commitment to advancing buntanetap into a longer study, which will allow us not only to verify observed symptomatic improvements but also to explore buntanetap's disease-modifying properties."

To view the webcast, visit https://ibn.fm/ijzvz

To view the full press release, visit https://ibn.fm/uUAVM

Annovis Bio Inc. (NYSE: ANVS) is a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (AD) and Parkinson’s Disease (PD). Annovis Bio stands out by developing a drug that targets multiple neurotoxic proteins simultaneously, aiming to restore axonal and synaptic activity. This innovative approach aims to treat memory loss and dementia associated with AD and body and brain dysfunction associated with PD, making Annovis a unique player in the neurodegeneration space.

Lead Drug Candidate: Buntanetap

Buntanetap (formerly Posiphen) targets neurodegeneration by inhibiting the formation of multiple neurotoxic proteins, including amyloid beta, tau, alpha-synuclein, and TDP43. This multifaceted inhibition improves synaptic transmission and axonal transport, reduces neuroinflammation, and protects nerve cells from dying. Unlike monoclonal antibody therapies, Buntanetap is an orally available small molecule capable of inhibiting multiple neurotoxic proteins at once, positioning it as a comprehensive solution for neurodegenerative diseases.

In a recent Phase II/III Alzheimer’s study, Buntanetap demonstrated statistically significant efficacy. Patients with early AD showed a significantly higher rate of improvement in ADAS-Cog 11 scores across all treatment doses compared to placebo, with a -3.3 point improvement compared to -0.3 for placebo (p < 0.01). Plasma Tau protein levels also reduced, consistent with previous Phase II biomarker data, further validating Buntanetap’s mechanism of action.

Similarly, in the Phase III study of Buntanetap in patients with early Parkinson’s disease, significant advancements were observed. Topline data results are anticipated in June 2024. Preliminary findings indicate promising results in improving cognitive and motor function, underscoring Buntanetap’s potential as a transformative therapy for Parkinson’s disease.

Market Opportunity

The aging population presents a significant market opportunity, with nearly 7 million Americans currently suffering from Alzheimer’s Disease (AD), a figure projected to rise to almost 13 million by 2050 (Alzheimer’s Association) (Republican Policy Committee). Additionally, approximately 1.2 million people in the U.S. have Parkinson’s Disease (SingleCare).

The economic burden of Alzheimer’s is immense, with care costs expected to reach $360 billion in 2024 and escalate to nearly $1 trillion annually by 2050. The need for effective, comprehensive treatments like Buntanetap is more critical than ever.

Company Highlights

  • Innovative Therapeutic Approach: Annovis Bio uniquely targets multiple neurotoxic proteins, aiming to restore nerve cell health and improve cognitive and motor function in AD and PD patients.
  • Robust Clinical Data: Phase II/III studies show significant improvements in cognitive function and biomarker levels in early AD patients.
  • Groundbreaking Clinical Insights: Preliminary results from Phase II studies indicate significant improvements in motor functions and speed in patients with Parkinson’s Disease (PD).
  • Upcoming Phase III Trials: Plans are underway for an 18-month Phase III trial focusing on biomarker-positive early AD patients, designed to further validate Buntanetap’s disease-modifying potential.
  • Capital Efficiency: Annovis Bio is capital-efficient, with zero debt and multiple global patents extending into the 2040s.

Management Team

Maria L. Maccecchini, Ph.D., Founder, President, CEO, and Executive Board Member, founded Annovis Bio in May 2008 with the mission to develop better therapeutics for Alzheimer’s, Parkinson’s, and other neurodegenerative diseases. She has previously been a partner and director at two angel groups, Robin Hood Ventures and MidAtlantic Angel Group, and founded Symphony Pharmaceuticals/Annovis, which was sold to Transgenomic in 2001. Her extensive experience includes roles such as General Manager at Bachem Bioscience and Head of Molecular Biology at Mallinckrodt. Dr. Maccecchini holds a Ph.D. in biochemistry from the Biocenter of Basel, with postdoctoral work at Caltech and the Roche Institute of Immunology.

Cheng Fang, Ph.D., Senior VP of Research and Development, is an accomplished neuroscientist with two decades of experience in neurodegenerative diseases. She has a successful track record of scientific publications and contributions, coupled with extensive pre-clinical and clinical development experience. Dr. Fang has been instrumental in advancing the understanding of neurodegenerative disease mechanisms and developing therapeutic strategies.

Michael Christie, Ph.D., VP of Process Chemistry, has over 40 years of experience in the pharmaceutical industry, focusing on process chemistry R&D, pilot plant production, and GMP operations. He has held senior management positions at companies such as SmithKline, Rhodia, Teva, and Cephalon, and founded a contract process R&D service company, which was later acquired by ChiRex. Dr. Christie is co-author or co-inventor on several publications and patents. He earned his BS in chemistry from the University of Michigan and his doctorate from MIT.

Melissa Gaines, Senior VP of Clinical Operations, is an accomplished clinical research professional with over 20 years of experience across academia, contract research organizations, and pharmaceutical companies. She has proven abilities in monitoring and managing Phase I to IV clinical trials, specializing in CNS disorders and extending to a broad range of therapeutic indications. Her CNS experience spans from small Phase I and II studies to large global Phase III trials in Alzheimer’s disease, Parkinson’s disease, sleep disorders, and various psychiatric diseases in both adult and pediatric populations. In her current role, she oversees and supports all clinical project activities, driving operational success and ensuring high-quality clinical outcomes.

Learn more about the Annovis Bio team on LinkedIn.

Annovis Bio Inc. (NYSE: ANVS), closed Tuesday's trading session at $9.28, up 76.0911%, on 40,734,248 volume. The average volume for the last 3 months is 552,592 and the stock's 52-week low/high is $4.53/$22.49.

Recent News

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI)

The QualityStocks Daily Newsletter would like to spotlight Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI).

Scinai Immunotherapeutics (NASDAQ: SCNI), a biopharmaceutical company focused on the development of inflammation and immunology ("I&I") biological products and on providing contract development and manufacturing organization ("CDMO") services through its Scinai Bioservices business unit, is reporting on its financial results for the quarter ended March 31, 2024; the company also released a business update. Notable financial numbers include R&D expenses for the three-month period totaling $1,568,000; marketing, general and administrative expenses totaling $484,000; financial income totaling $231,000; and net loss reported at $2,159,000; the company also reported cash and cash equivalents and short-term deposits of $4,826,000 as of March 31, 2024. Business highlights include raising $1.69 million in gross proceeds from the exercise of outstanding warrants and the issuance of new warrants as well as regaining compliance with NASDAQ's minimum $1 bid price requirement. Scinai also received a letter of intent from the EIB outlining the terms for converting the EIB's loan into equity. The company's contract development and manufacturing organization ("CDMO") business unit received work orders valued at approximately $500,000 and is in advanced contract discussions with other potential clients. Scinai is also advancing its NanoAb preclinical development, including preparations for a preclinical toxicology study before beginning a first-in-human clinical trial of a proprietary anti-IL NanoAbs for the treatment of plaque psoriasis and research in additional NanoAbs for treatment of autoimmune diseases such as asthma, atopic dermatitis and wet AMD. Based on current projections and expectations, the company maintains its sales guidance for 2024 of $1.25 million in expected revenues.

To view the full press release, visit https://ibn.fm/zZ7tu

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI) is a biotechnology company focused on developing, manufacturing, and commercializing innovative immunotherapeutic products primarily for the treatment of infectious diseases and autoimmune diseases.

In collaboration with the prestigious Max Planck Institute for Multidisciplinary Sciences (MPG) and the University Medical Center Göttingen (UMG), both in Germany, Scinai is developing a pipeline of innovative nanosized antibody (NanoAb) therapies addressing diseases underserved by current treatments and with large and growing markets, such as COVID-19, asthma and psoriasis.

NanoAbs, also known as VHH-antibodies or Nanobodies, are alpaca-derived nanosized antibodies that exhibit multiple significant competitive advantages over existing antibody therapies, including stability at high temperatures, superior binding affinity, more effective and convenient routes of administration and efficient production. Scinai is uniquely positioned to advance nanosized antibody innovation from R&D through commercialization.

The company’s highly experienced and successful pharmaceutical industry leadership team includes former senior executives from Novartis, GSK and Bristol-Myers Squibb.

Since its founding, Scinai has executed eight clinical trials, including a seven-country, 12,400-participant Phase 3 trial of a prior influenza vaccine candidate, and it built, owns and operates a 20,000 sq. ft. state-of-the-art GMP biologics manufacturing facility housing its laboratories, production facilities and offices.

Lead Candidate: Inhaled COVID-19 NanoAb

In December 2021, Scinai signed definitive agreements with the Max Planck Society – parent organization of the Max Planck Institute for Multidisciplinary Sciences– and the UMG to enter a strategic collaboration for the development and commercialization of innovative COVID-19 NanoAbs.

The company is planning a rapid development path that leverages its expertise and capabilities in biological drug development and manufacturing. Scinai anticipates preclinical proof-of-concept results for an inhaled COVID-19 NanoAb by the end of 2022, with initial Phase 1/2a human clinical trial results expected in 2023.

The intended inhaled mechanism of delivery of Scinai’s COVID-19 NanoAb formulation may serve as a significant differentiator when compared to approved monoclonal antibodies, which are injected. Inhaled delivery has shown to be cheaper, more convenient and likely safer for patients and providers.

NanoAb Pipeline: Psoriasis, Asthma and More

The COVID-19 NanoAb development agreement is part of a broader five-year research collaboration agreement signed in March 2022 covering discovery, development and commercialization of NanoAbs for several other disease indications with large market medical needs, including asthma, psoriasis, macular degeneration and psoriatic arthritis.

Scinai has an exclusive worldwide license for development and commercialization of COVID-19 NanoAbs and exclusive options for similar worldwide licenses for NanoAbs for the above mentioned additional large market disorders currently underserved by approved therapeutic antibodies.

Academic research teams from MPG and UMG have verified strong affinity by the new NanoAbs to their biological target molecules and high thermostability. They have also demonstrated strong neutralization by several NanoAb candidates of their respective target molecules. Neutralization studies of the other NanoAbs are expected to begin later in 2022.

Based on the promising results, Scinai will focus development efforts beginning with the following NanoAbs:

  • NanoAbs targeting IL-17 as drug candidates for the potential treatment of psoriasis and psoriatic arthritis
  • NanoAbs targeting IL-13 and NanoAbs targeting TSLP as drug candidates for the potential treatment of asthma

These are conditions for which the antibody target is validated by existing treatments and the mechanism of action is well understood. Both represent large medical needs and growing markets. Scinai anticipates preclinical proof-of-concept for at least one of these NanoAbs in 2023. This is in addition to the aforementioned human clinical Phase 1/2a for the inhaled COVID-19 NanoAb therapy, which is also anticipated in 2023.

CDMO Services

While NanoAb pipeline development is Scinai’s core focus, the company also offers its cGMP manufacturing facility, aseptic fill and finish suite, laboratories and experienced professionals for contract development and manufacturing organization (CDMO) services. This offering is designed to keep the Scinai team abreast of the latest industry developments and trends while building experience and generating revenue to support the company’s NanoAb pipeline development.

Market Opportunity

COVID-19 treatment, target of the company’s lead NanoAb therapy candidate, had an estimated market size of $22 billion in 2021.

Future Scinai drug candidates will target conditions with large markets growing at attractive CAGRs.

The global asthma treatment market was valued at $18.08 billion in 2019 and is projected to reach $26.01 billion by 2027, exhibiting a CAGR of 4.5% during the forecast period, according to Fortune Business Insights. The research firm predicts that the global psoriasis treatment market will grow from $26.37 billion in 2022 to $47.24 billion by 2029, exhibiting a CAGR of 8.7% over the forecast period.

Management Team

Amir Reichman is Scinai’s CEO. He previously was Head of Global Vaccines Engineering Core Technologies at GSK Vaccines in Belgium. Prior to that, he held leadership roles at Novartis Vaccines’ Global Vaccines Supply Chain Management organization. He was the first employee of NeuroDerm Ltd., a company focused on transdermal drug delivery, and served as Senior Scientist until his departure in 2009. He earned a M.Sc. in Biotechnology Engineering from Ben-Gurion University and an MBA in Finance and Health Care Management from the University of Pennsylvania’s Wharton School.

Tamar Ben-Yedidia, Ph.D., is Chief Science Officer at Scinai. She has more than 30 years of experience in immunology, with specific expertise in the development of vaccines. She began her career with Biotechnology General Ltd., working on development of a recombinant Hepatitis-B vaccine. She later joined the Weizmann Institute of Science, working on the design of a peptide-based vaccine against several pathogens. She is widely published, with numerous refereed articles and invited reviews in various scientific journals. She received her Ph.D. from the Weizmann Institute.

Elad Mark is COO at Scinai. He has over 15 years of biotechnology industry experience encompassing diverse project stages including feasibility studies, conceptual and detailed design, commissioning, qualification and process validation. Prior to joining Scinai, he led Novartis’s $800 million investment in a biologics facility in Singapore. With Biopharmax and Antero, both global pharmaceutical engineering companies, he successfully led projects in Israel, China and Singapore. He holds a BSc. in Engineering from the Afeka Tel Aviv Academic College of Engineering and an MBA from the Open University of Israel.

Uri Ben-Or is CFO at Scinai. He has served as CFO with public life science companies traded on the TASE, OTC and Nasdaq. Ben-Or provides his services to Scinai through CFO Direct, a company he founded and for which he serves as CEO. He served as the VP of Finance of Glycominds, a leading biotechnology company, and as CFO of a spin-off from Telrad Networks. He also served as a Corporate Controller at Menorah Capital Markets and as an Auditor at PWC. He holds a B.A. in Business from the College of Administration, an MBA from Bar-Ilan University, and is a CPA.

Scinai Immunotherapeutics Ltd. (NASDAQ: SCNI), closed Tuesday's trading session at $2.98, up 1.3605%, on 32,870 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $22.49/$.

Recent News

Mullen Automotive Inc. (NASDAQ: MULN)

The QualityStocks Daily Newsletter would like to spotlight Mullen Automotive Inc. (MULN).

Mullen Automotive (NASDAQ: MULN), an electric vehicle ("EV") manufacturer, is reporting the sale of its first electric vehicle in Massachusetts through its new dealer partner, Eco Auto; the two announced their partnership last month. According to the announcement, Eco Auto made the sale to a Massachusetts-based company that provides custom home building, home renovations and maintenance, property management and painting services. Eco Auto is a national franchise of automotive dealerships that focus on offering a comprehensive electric vehicle experience by providing affordable EVs, hybrid models, advanced charging stations and expert EV service. "We are thrilled to announce the first Mullen commercial EV sale in Massachusetts with our valued partner, Eco Auto," said Mullen Automotive CEO and chair David Michery in the press release. "We are confident that our commercial EVs will be a game-changer for businesses looking to electrify in Massachusetts, offering them a reliable, efficient, and environmentally friendly transportation solution."

To view the full press release, visit https://ibn.fm/gnM25

Mullen Automotive Inc. (NASDAQ: MULN) is a Southern California-based automotive company that owns and partners with several synergistic businesses working toward the unified goal of creating clean and scalable energy solutions. Mullen has evolved over the past decade in sync with consumers and technology trends. Today, the company is working diligently to provide exciting EV options built entirely in the United States and made to fit perfectly into the American consumer’s life. Mullen strives to make EVs more accessible than ever by building an end-to-end ecosystem that takes care of all aspects of EV ownership.

Commencement of Trading on Nasdaq

On November 5, 2021, Mullen announced its commencement of trading on the Nasdaq Capital Market.

“Today is a monumental day for Mullen Automotive. I am especially proud of our team, investors and all who have believed in Mullen and taken us to this point as a publicly traded company on the Nasdaq Capital Market,” David Michery, CEO and Chairman of Mullen Automotive, stated in the news release. “Trading on Nasdaq now opens us up to new investors, both institutional and retail shareholders, and broadens our awareness and company profile, while increasing awareness of Mullen and our technology platform and opening new opportunities in EV and beyond. The road ahead has never been brighter for Mullen, and I am proud to lead us into the future.”

The milestone came in the wake of the company’s stock-for-stock merger with Net Element Inc.

The Mullen FIVE

The Mullen FIVE EV Crossover, debuting at the Los Angeles International Auto Show (LAIAS) on November 17, 2021, embodies Mullen’s Southern California roots with an inspired design focused on two complementary Golden State themes – California landscape and California urban.

The FIVE is built on an EV Crossover skateboard platform that offers multiple powertrain configurations and trim levels in a svelte design that is Strikingly Different™ and exciting to experience in person.

Prior to the start of LAIAS, the Mullen FIVE was selected as a finalist by the LA Auto Show for Top EV SUV in the ZEVA “People’s Choice” Awards.

LAIAS provides Mullen an opportunity to display multiple variants of the FIVE model while also showcasing its powertrain, battery and charging technology. The company intends to bring the FIVE to market in 2024, and reservations are currently open here.

Mullen’s development portfolio also includes EV Fleet Vans, which it intends to bring to market in Q2 2022, and the pure electric, high performance Mullen DragonFLY.

Expansion of Manufacturing Capacity

On November 2, 2021, Mullen announced plans to expand its facility in Robinsonville, Mississippi.

Mullen’s Advanced Manufacturing and Engineering Facility (AMEC) currently occupies 124,000 square feet of manufacturing space. The total available land on the property is over 100 acres, and Mullen is moving ahead with plans to build out another 1.2 million square feet of manufacturing space to support class 1 and class 2 EV cargo vans and the Mullen FIVE EV Crossover.

On the expanded site, Mullen plans to build a body shop, a fully automated paint shop and a general assembly shop.

EV Market Outlook

The global EV market was reported to consist of 3,269,671 units in 2019, a figure that is expected to grow at a CAGR of 21.1% through 2030 to a total of 26,951,318 units worldwide. This market’s monetary value was estimated at $162.34 billion in 2019 and is expected to grow at a CAGR of 22.6%, resulting in an approximate value of $802.81 billion by 2027. The primary driver for this exponential growth is a worldwide increase in vehicle emissions regulations.

Management Team

David Michery is the CEO and Founder of Mullen and has been leading the company and its divisions since inception in 2014. With over 25 years of executive management, marketing, distressed assets, and business restructuring experience, Mr. Michery brings a wealth of relevant knowledge and expertise to the Mullen brand. He has notably created 12 trademarks so far to develop the company brand and vision.

Mr. Michery is working toward a sustainable future accessible to all by creating a suite of clean-energy electric vehicles at varied price points. With entirely U.S.-based manufacturing and operations, he is also determined to have Mullen Technologies play a role in shaping a self-sustaining local economy by creating more jobs in America.

Mr. Michery manages risks and company expectations as a pathway to success and has personally overseen several businesses that totaled over $1 billion in transactions. His key strength is the ability to be fiscally responsible and lead teams to complete projects on time and within budget. As a seasoned professional in this space, Mr. Michery has demonstrated skill in building businesses from the ground up and into successful entities that subsequently sold for hundreds of millions of dollars.

Mullen Automotive Inc. (MULN), closed Tuesday's trading session at $2.34, off by 3.3058%, on 1,001,936 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $2.30/$289.08.

Recent News

NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW)

The QualityStocks Daily Newsletter would like to spotlight NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW).

NextPlat (NASDAQ: NXPL, NXPLW), a global e-commerce provider, today announced that it has expanded its e-commerce development program in China through a new agreement with a leading Chinese healthcare and nutritional products marketing and distribution services partner (the "marketing partner"). According to the update, the marketing partner will provide NextPlat with a full range of creative content, brand marketing and product sales and distribution services and support the company's exclusive joint e-commerce development agreement with OPKO Health Europe , a subsidiary of OPKO Health, Inc. (NASDAQ: OPK). "Our unique e-commerce development program was created to provide American companies with turn-key online sales, marketing and distribution access into the large Chinese consumer market without requiring the significant international infrastructure investments typically required," said Charles M. Fernandez, executive chairman and CEO of NextPlat. "Through the addition of well-established marketing specialists in China, we believe we can provide our clients with a greater array of value-added services which can help drive product awareness and revenue."

To view the full press release, visit https://ibn.fm/e7XuH

Last week Web3 unveiled Propeller.chat, a new decentralized application (DApp) built on an open-source communications protocol, to revolutionize product reviews and bring users and creators closer together. One of the key goals of Web3 developers is to develop products that improve user engagement. Described as a "Trustpilot for Web3," this new platform harnesses blockchain technology to draw key comparisons to popular online reviews and rating sites. According to Brian Meek, cofounder and chief technology officer of HNT Labs, with the changes currently ongoing in the industry, users need products that are aligned with their needs and preferences. With this new DApp, creators can produce top-notch products with features tailored to specific needs. The platform aims to solve challenges that users have endured by using centralized platforms, including fake reviews and control of user data, among others. Through Web3 technology, users gain access to a more trustworthy and cooperative digital ecosystem. As Web3 continues to evolve, DApps such as Propeller.chat will change how trust is built and maintained online. These platforms offer a new pattern of transparency, authenticity and user empowerment. With the launch of this new Dapp and the other related industry developments such as the way in which companies such as NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW) are deploying Web3 technologies in their operations, it looks as if Web3 is fast approaching a tipping point that will see it become mainstream in all industries.

NextPlat Corp. (NASDAQ: NXPL) (NASDAQ: NXPLW), a next generation e-commerce platform, was created with vision and purpose to capitalize on high growth sectors and global markets. The company collaborates with businesses – large and small – to simplify and accelerate online commerce and uniquely enables customers and partners to optimize their e-commerce reach, presence and revenue. NextPlat recently launched a new e-commerce development program to provide American businesses with easy access to the massive Chinese consumer market.

Current Initiatives

NextPlat provides cutting edge technology in an advanced e-commerce ecosystem. The company is actively expanding its global network of online storefronts serving thousands of consumers, enterprises and governments. The company also has developed a next generation platform built for Web3 that enables the creation and sale of digital assets, as well as optimizing e-commerce transactions and business building activities. The company’s current initiatives include:

  • E-Commerce Development Program – In April 2023, NextPlat announced it had entered into a merchant sourcing agreement with Alibaba.com Singapore E-Commerce Private Limited (“Alibaba”) and its Tmall Global e-commerce platform whereby the two companies will collaborate to increase the sale of products produced and sold by American companies to the multi-trillion-dollar Chinese consumer market. Alibaba’s Tmall Global e-commerce platform will provide NextPlat customers a turn-key solution through which products can be sold to the Chinese consumer market. The launch of the Florida E-Commerce Development Program is the first in a series of new NextPlat programs designed to assist U.S. businesses in expanding their online sales capabilities to reach new international customers in the Chinese market. NextPlat intends to rapidly expand this unique e-commerce development opportunity to businesses throughout the United States and all of North America, as well as Central and South America. The new development program features NextPlat’s turnkey global e-commerce solution for customers and leverages NextPlat’s relationships with key partners, including Tmall Global, China’s largest cross-border B2C online marketplace.
  • Progressive Care Inc. – In August 2022, NextPlat completed a strategic $7 million investment in Progressive Care Inc. (OTCQB: RXMD), a personalized health care services and technology company. In a news release announcing the investment, NextPlat CEO Charles M. Fernandez noted that the company is “committed to harnessing the power of digital technologies to capitalize on the ongoing digital transformation of Progressive Care and the entire health care industry.” NextPlat intends to accelerate Progressive Care’s digital health care transformation with the launch of a new e-commerce platform for health care products later this year.
  • NextPlat NFT Platform – Building on its existing e-commerce initiatives, NextPlat is working to bridge the gap between tangible and digital e-commerce marketplaces by incorporating burgeoning Web3 technologies. The company intends to launch a fully integrated NFT platform in the coming months that will enable brands to create, manage and authenticate digital assets while serving as a new source of revenue for NextPlat. Through this model, the company will receive a portion of the revenue generated from branded NFT drops, as well as subsequent secondary market transactions.
  • Global Telesat Communications and Orbital SatCom Corp. – Targeting both domestic and international markets, NextPlat’s subsidiaries leverage partnerships with major e-commerce platforms such as Amazon, Alibaba, eBay and Walmart to serve a growing base that includes more than 50,000 corporate, governmental and individual customers. In total, the brands market more than 10,000 individual products, with a focus on satellite-based connectivity solutions. In addition to exploring accretive M&A opportunities, NextPlat aims to diversify its range of products and broaden its geographic footprint moving forward in an effort to better capitalize on the tremendous growth potential in the United States, Europe and Asia.

“Our goal for 2023 and beyond is to leverage our improved operational capabilities and enhanced leadership team as we expand our offerings in communications and connectivity into the high-growth health care market where we intend to launch an array of innovative new offerings,” Fernandez said in a March 2023 news release detailing the company’s record top-line performance. “Although there remain supply chain headwinds and the challenge of global inflation, we are confident that we have the right combination of market-tested expertise, technology and partnerships that will enable us to bring the power of e-commerce to more customers, brands and industries in the United States and abroad.”

Market Opportunity

The rapid growth of e-commerce over the last decade is expected to continue for the foreseeable future. According to data published by Forbes, roughly 20.8% of all retail purchases are expected to take place online in 2023, accounting for total sales of $6.31 trillion worldwide. It total, e-commerce sales are expected to grow by 10.4% YoY in 2023, accounting for a whopping 24% of all retail purchases by 2026.

For NextPlat, existing partnerships in the industry could be key to capitalizing on this growth. The Forbes report indicates that Amazon accounts for roughly 38.7% of e-commerce sales, while sites like Walmart, eBay and Alibaba round out the list of most visited e-commerce websites. Alibaba is especially interesting due to NextPlat’s recent strategic merchant sourcing agreement with Tmall Global. The Chinese market is “mammoth,” as a recent Alizila report noted. The country’s annual online retail sales of physical goods have nearly doubled in the last five years, reaching approximately 13.8 trillion yuan in 2022, which is nearly $2 trillion USD.

The health care portion of the e-commerce market is generating particularly bullish forecasts, bolstered by the continued adoption of the 340B Drug Pricing Program in the U.S., which requires most drug manufacturers to provide outpatient drugs to covered entities at significantly reduced prices. Industry reports suggest that the global health care e-commerce market will expand at a compound annual growth rate of 16.8% from 2022 to 2030, climbing to a value of more than $1.37 trillion by the end of the forecast period.

Management Team

Charles M. Fernandez, CEO, Executive Chairman and Director of NextPlat, has over three decades of experience in identifying profitable start-up and dislocation opportunities, building significant value and executing exit strategies as an entrepreneur and global investor. Successful across multiple sectors, Fortune Magazine actually labeled Fernandez ‘a restructuring whiz’. As President of Fairholme Capital Management, which he joined in 2008, Mr. Fernandez co-managed all three Fairholme funds and brought in a $2 billion gain for shareholders. Throughout his impressive career, he has participated in more than 100 significant mergers, acquisitions and product development projects across multiple industries. Mr. Fernandez was the founder, Chairman and CEO of eApeiron Solutions LLC, a brand protection and e-commerce company in partnership with Alibaba (NYSE: BABA) and Eastman Kodak (NYSE: KODK), which was successfully sold to Smartrac, a unit of Avery Dennison Corp. (NYSE: AVY).

Rodney Barreto is Chairman and CEO of the Barreto Group and Director of Nextplat. Mr. Barreto’s business career spans over 35 years, including his role at the Barreto Group and, earlier, as the founding partner of Floridian Partners LLC, a corporate and public affairs consulting firm recognized by policy makers as one of the top in its industry in Florida. He chaired the Super Bowl Host Committee in 2007, 2010 and 2020, helping to raise more than $100 million for the success of Miami Super Bowls. As a philanthropist and conservationist, Mr. Barreto is also a three-time appointee to the Florida Fish and Wildlife Conservation Commission, where he has served for over 10 years including holding the title of Chairman eight times. He has twice chaired the Annual U.S. Conference of Mayors, was Chairman of the 1999 Breeder’s Cup Championship held in South Florida and was the Chairman of the 1999 Sister Cities International Convention in Miami. Currently, Mr. Barreto is the Membership Chairman of the Florida Council of 100, and a member of the Boards of Fairchild Tropical Botanic Garden, the Baptist Health South Florida Giving Society, the Bonefish and Tarpon Trust, the Guy Harvey Ocean Foundation, and a member of Miami Dade County Schools Superintendent Carvalho’s Business Advisory Council. Prior to his career in public affairs and real estate, Mr. Barreto was a City of Miami police officer and is a member of the Florida Highway Patrol Advisory Council.

NextPlat Corp. (NXPL), closed Tuesday's trading session at $1.06, off by 0.9345794%, on 22,168 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.03/$3.08.

Recent News

SuperCom Ltd. (NASDAQ: SPCB)

The QualityStocks Daily Newsletter would like to spotlight SuperCom Ltd. (NASDAQ: SPCB) .

SuperCom Ltd. has developed its PureSecurity Suite of products as an end-to-end electronic monitoring ("EM") solution to meet the needs of correctional facilities and law enforcement agencies, providing them with the tools they need to manage offenders effectively, prevent domestic violence, and ensure public safety

A study published earlier this year in the Journal of Public Economics provided a basis for measuring the benefits of EM programs, not only showing reduced recidivism and prison costs, but also increased worker productivity and children's educational performance

The study on Sweden's nationwide EM alternative for low-level criminal offenses showed the probability of being re-arrested within three years after trial dropped, and suggests that the annual earnings of children whose parents are placed on EM will increase as they reach adulthood

SuperCom recently reported its quarterly financial results, noting growth in its revenues, EBITDA, and operating income for record profitability

As societies worldwide grapple with curtailing criminal behavior, they might well take inspiration from a study of Sweden's electronic monitoring ("EM") program providing a remote, automated alternative to incarceration for the lowest tier of criminal offenses (non-violent crimes resulting in imprisonment up to three months). SuperCom (NASDAQ: SPCB) is a company specializing in EM security solutions that is helping to promote the benefits of such alternative programs for its criminal justice system clients in the United States and European countries such as Sweden, Croatia, Finland, and Romania. "The substantial growth in our gross profit reflects the inherent quality and high-margin potential of our key projects and our successful progression through different stages of these projects," SuperCom President and CEO Ordan Trabelsi stated following publication of the company's first quarter financial results last month, which included emphasis that SuperCom's EBITDA grew by 400 percent YOY as a measure of the company's profitability (https://ibn.fm/XcsCH).

SuperCom Ltd. (NASDAQ: SPCB) provides secured solutions for the e-government, IoT and cybersecurity sectors. Since 1988, the company has been a trusted global provider of traditional and digital identity offerings, providing cutting-edge electronic and digital security solutions to governments and organizations, both private and public, around the world.

SuperCom’s mission is to revolutionize the public safety sector worldwide through proprietary electronic monitoring technology, data intelligence, and complementary services.

The company is headquartered in Tel Aviv, Israel, with offices in California and other regions in the U.S.

Business Units

IoT and Connectivity

SuperCom IoT products and solutions provide advanced electronic monitoring solutions and services to criminal justice agencies, enabling customers to detect unauthorized movement of people, vehicles, and other monitored objects. The company provides an all-in-one, field-proven PureSecurity offender monitoring suite, accompanied by services such as GPS monitoring, home detention, domestic violence prevention, and more. The company’s services are specifically tailored to meet each client’s needs.

SuperCom’s proprietary Puresecurity suite of hardware, connectivity, and software components is the foundation for its criminal justice services and offerings. SuperCom is leveraging its extensive technology expertise to implement groundbreaking artificial intelligence (AI) technologies into various parts of its core offerings. By leveraging the power of AI, SuperCom’s PureSecurity platform can offer new abilities, such as amplified data analysis, predictive modeling, and streamlined automation – all geared toward optimizing decision-making and operational efficiency.

Competitive advantages of SuperCom’s technology include:

  • Long Battery Life (No Tag Charging Required)
  • Ultra Lightweight Form Factor
  • Next-Gen Location Tech
  • Protection of Domestic Violence Victims
  • And More

 

Cybersecurity

In 2015, SuperCom identified the cybersecurity market as a fast-growing space with significant advantages due to synergistic technologies and a shared customer base with its e-Gov and IoT business units. Consequently, SuperCom strategically acquired Prevision Ltd., a company with a strong presence in the market and a broad range of competitive cybersecurity services.

During the first quarter of 2016, SuperCom acquired Safend Ltd., an international provider of cutting-edge endpoint data protection guarding against corporate data loss and theft through content discovery and inspection, encryption methodologies, and comprehensive device and port control.

Both acquisitions significantly expanded the breadth of the company’s global cybersecurity capabilities.

e-Gov

Through proprietary e-government platforms and innovative solutions for traditional and biometrics enrollment, personalization, issuance, and border control services, SuperCom has helped governments, and national agencies design and issue secured multi-identification, or Multi-ID, documents and robust digital identity solutions to their citizens, visitors, and lands.

The company has focused on expanding its activities in the traditional identification, or ID, and electronic identification, or e-Gov, markets, including the design, development, and marketing of identification technologies and solutions to governments in Europe, Asia, America, and Africa using SuperCom’s e-Government platforms.

Market Opportunity

Data from Berg Insight estimates the market for electronic monitoring solutions will grow from $1.2 billion in 2021 to $2.1 billion in 2026, marking a CAGR of 10.8% for the forecast period.

High recidivism rates, prison overcrowding, and soaring incarceration costs are some factors that are driving the electronic monitoring of offenders’ market growth.

An analysis by ReportLinker forecasts that the global cybersecurity market will grow from an estimated value of $173.5 billion in 2022 to $266.2 billion by 2027, achieving a CAGR of 8.9% for the period.

The increased number of data breaches worldwide, the ability of malicious actors to operate from anywhere in the world, the links between cyberspace and physical systems, and the difficulty of reducing vulnerabilities and consequences in complex cyber networks are some factors driving the cybersecurity market growth.

Management Team

Ordan Trabelsi is President and CEO of SuperCom. He has over 15 years of experience as CEO, growing high-tech companies globally. He also has experience in research and development and product innovation, as well as hands-on experience in cybersecurity, encryption, advanced mathematics, and mobile and internet network technologies. Prior to joining SuperCom, he served as co-founder and CEO of Klikot Inc., a global social networking company. He holds an MBA from Columbia University and a B.Sc. in Computer Engineering from The Technion: Israel Institute of Technology.

Barak Trabelsi is COO of SuperCom. He has expertise in big data, cyber, mobile, and internet network technologies, as well as extensive experience in product development and strategies. Prior to joining SuperCom, he served as Senior Product Manager at Equinox Ltd. Before that, he served for four years as VP of R&D at Sigma Wave, a wireless, security, and internet-focused company. He holds a B.Sc. in Computer Science and Business, as well as an MBA from Tel Aviv University.

Gil Alfi is VP of Sales at Safend Ltd., SuperCom’s cybersecurity subsidiary. He joined SuperCom in 2016 as VP of Business Development for Safend. He has more than 18 years of experience in technology companies. He served as an R&D team technology lead for more than seven years and as Director of Product Management for various telecom and wireless companies for more than 10 years. Prior to joining SuperCom, he served as Regional Sales Director at Safend, managing sales regions in Europe and Africa. He holds a B.Sc. in Computer Science and Mathematics and an M.Sc. in Computer Science from Bar-Ilan University.

SuperCom Ltd. (NASDAQ: SPCB), closed Tuesday's trading session at $0.1906, off by 2.0555%, on 1,318,259 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.1524/$1.19.

Recent News

SOBRsafe Inc. (NASDAQ: SOBR)

The QualityStocks Daily Newsletter would like to spotlightFathom SOBRsafe Inc. (NASDAQ: SOBR).

SOBRsafe recently signed hardware/software agreements with Lighthouse Recovery Resources and Mountain House Recovery, both operating in the U.S. behavioral health segment

The two new agreements bring the number of new accounts secured in 2024 to 20, compared to three accounts booked in all of 2023

The company is targeting the behavioral health and justice segments, which mandate the use of alcohol testing

According to SOBRsafe's CEO, while businesses and services in the behavioral health and justice segments already use different alcohol testing technologies, they are hungry for evolved solutions

SOBRsafe offers SOBRcheck(TM) and SOBRsure, designed to instantaneously detect and report the presence of alcohol as emitted through the skin

SOBRsafe (NASDAQ: SOBR) provides next-generation transdermal alcohol detection technology, which simplifies the alcohol detection process. The proprietary technology combines an NIAAA-awarded gas sensor with proprietary algorithms to capture alcohol vapor emitted through pores, detecting alcohol 2-3x faster than other transdermal solutions with accuracy that approaches 99% at heavy consumption levels (https://ibn.fm/371c7). The technology can be found in the company's suite of products: SOBRcheck(TM), a high-volume passive alcohol screening solution for stationary use, and SOBRsure(TM), a wearable wristband that provides continuous, mobile alcohol monitoring.

SOBRsafe Inc. (NASDAQ: SOBR) is a provider of a game-changing transdermal (touch-based) alcohol detection technology that can improve workplace safety and provides advanced screening and monitoring solutions for the behavioral health industry.

Alcohol misuse is the fourth leading cause of preventable death in the U.S., and the seventh worldwide. Nearly half of all industrial accidents with injuries are alcohol-related, and 1-in-10 U.S. commercial drivers tests positive for alcohol – the highest rate in the world. Despite these statistics, prevention and monitoring solutions have not kept pace with this epidemic. Legacy detection technologies are invasive and inefficient, unhygienic and unconnected. SOBRsafe believes there is a better way.

The company has developed a patent-pending alcohol detection device called SOBRcheck™ for use in detecting alcohol in humans, with just the touch of a finger. SOBRsafe’s next-generation transdermal technology detects and instantaneously reports the presence of alcohol as emitted through a user’s skin. No breath, blood or urine sample is required. SOBRsafe believes its technology is a superior, hygienic alternative to traditional breathalyzers for frontline, preventative applications.

With a powerful backend data platform, SOBRsafe provides humane, passive and connected alcohol detection for the behavioral health, transportation, oil and gas, judicial and consumer markets.

A preventative solution in historically reactive industries, SOBRsafe technology is being deployed for commercial fleets, workplaces, alcohol rehabilitation, probation management and teen drivers. This monitoring technology helps prevent intoxicated workers from taking the factory floor or drivers from receiving the keys to a truck, bus or family car. An offender is immediately flagged, and an administrator is empowered to take the appropriate corrective actions.

SOBRsafe technology is commercially available for access control (SOBRcheck), wearable use (SOBRsure™) and licensing or white labeling.

The company is headquartered in the Denver (CO) Technology Center.

Products

The SOBRsafe technology is integrated within the company’s robust and scalable data platform, producing statistical and measurable user and business data.

SOBRsafe™

With a mission is to save lives, increase productivity, create significant economic benefits and positively impact behavior, SOBRsafe developed the scalable, patent-pending SOBRsafe™ platform for non-invasive alcohol detection, real-time reporting and historical data aggregation.

SOBRsafe is a solution that has broad applications in behavioral health, fleet and facility safety, youth drivers and judicial markets.

SOBRcheck™

SOBRcheck is the company’s stationary identification and alcohol monitoring product, providing a quick, specific-point-in-time test for the presence of alcohol. In hygienic, real-time fashion, SOBRcheck verifies user identity and determines the absence or presence of alcohol.

SOBRcheck provides an administrator immediate results – delivered securely – to aid in the efficient management of an existing substance abuse policy.

SOBRsure™

SOBRsure is the company’s transdermal, alcohol-detecting wearable. SOBRsure provides continuous, mobile alcohol monitoring. The band’s advanced alcohol safety technology discreetly detects and instantaneously reports the presence of alcohol in the body. Additionally, SOBRsure provides app-based alcohol detection alerts, pinpoint location tracking and band-removal notifications.

The SOBRcheck and SOBRsure revenue models consist of two components: (1) a hardware device purchase and (2) a recurring monthly SaaS subscription fee.

Design, manufacturing, quality testing and distribution for all SOBRsafe devices takes place in the U.S.

 

Market Opportunity

A report from Data Bridge Market Research, an international market research and consulting firm, estimated the global alcohol sensor market at $2.3 billion in 2022. The market is forecast to reach a value of $6.3 billion by 2030, recording a CAGR of 13.7% over the forecast period.

Market growth drivers, as cited by the report, include rising alcohol consumption rates, more stringent laws pertaining to alcohol consumption and new, more effective technologies that facilitate detection and enforcement.

Greater awareness of alcohol consumption as a potential threat to public and workplace safety has led to increased emphasis on preventing operation of motor vehicles and machinery by those under the influence of alcohol and promoting responsible alcohol consumption, as the report details.

Management Team

David Gandini is Chairman and CEO of SOBRsafe. He most recently served as president of IPS Denver, a bank card personalization company. Prior to that, Dave was the COO at First World Communications, a U.S. internet and data center provider, and participated in its successful IPO. He previously founded Pace Network Services and facilitated a successful exit to ICG Communications. Dave also co-founded Detroit-based Digital Signal in the fiber optic long haul market sector, where he executed a successful exit to SP Telecom.

Chris Whitaker, CPA, is CFO of SOBRsafe. Previously, Chris had served as the Company’s Vice President of Finance and Accounting. He has held various executive finance positions with large public multi-national corporations and small entrepreneurial companies throughout a progressive 30-year career that began with KPMG. Chris was formerly President – Americas and Vice President of Finance and Administration for public, multinational corporation Elixinol. He also served as the Managing Director of AEGIS Financial Consulting, leading a team of consultants in providing fractional CFO and financial consulting services to a wide variety of businesses in the public and private sectors.

Scott Bennett is EVP, Business Operations at SOBRsafe. He has more than 20 years of experience as a senior executive in technology-driven enterprises. Prior to joining SOBRsafe, he co-founded cybersecurity firm GBprotect and served as its COO until its successful sale to Nuspire. He previously served as Chief Technical Officer/Chief Information Security Officer of fintech businesses Catalyst Card Company and Integrated Printing Solutions.

SOBRsafe Inc. (NASDAQ: SOBR), closed Tuesday's trading session at $0.1455, off by 3%, on 2,187,425 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.128/$1.80.

Recent News

Golden Triangle Ventures Inc. (OTC: GTVH)

The QualityStocks Daily Newsletter would like to spotlight Golden Triangle Ventures Inc. (GTVH).

Golden Triangle Ventures (OTC: GTVH) ("GTV") today announced the availability of the replay for its highly anticipated July 1 Spaces event on X.com. The event was hosted by GTV's CEO, Steffan Dalsgaard, who delivered a complete overview of GTV's multifaceted business activities, including a key highlight of its flagship Destino Ranch project. During the live session, Dalsgaard provided comprehensive insights into the company's diverse business, strategic initiatives and ambitious future growth plans. The event garnered significant attention and was met with enthusiasm from shareholders and the general public, offering a rare glimpse into Golden Triangle Ventures' dynamic operations and visionary goals.

To view the full press release, visit https://ibn.fm/49zC1

Golden Triangle Ventures Inc. (OTC: GTVH) is a multifaceted consulting company pursuing ventures in the health, entertainment and technology industries, with many additional projects being developed that provide synergistic values to these divisions. The company aims to purchase, acquire and/or joint venture with established entities that management can help assist and develop into unique opportunities.

Additionally, GTVH provides a professional corporate representation service to different companies in these sectors while consulting on a variety of business development objectives. The goods and services represented are driven by innovators who have passion and commitment to these marketplaces.

The company plans to utilize relationships and create a platform for new and existing businesses to strengthen their products and/or services. The three points of the Golden Triangle exclusively represent these three sectors in which the company aims to do business.

Health Division – Global Health Services

Global Health Services is a wholly owned subsidiary of Golden Triangle Ventures (operating under its Health Division). Dedicated to the promotion of well-being and natural wellness, the company currently does business in the industrial hemp/CBD industry. Additionally, the company has a vision to promote, market and generate sales for a myriad of products and services which include a full retail line of high-end, all-natural health, wellness and beauty products.

To help achieve this vision, Global Health Services is in the process of further developing an extensive online portal that will support the multiple verticals under the company and provide a one-stop-shop for all of the company’s products and services. Moreover, to support overarching business goals, senior management tirelessly works on acquiring and building an array of profitable assets and projects.

Entertainment Division – Lavish Entertainment

Lavish Entertainment (EpicRaves) is a wholly owned subsidiary of Golden Triangle Ventures under its Entertainment Division. Operating out of Las Vegas, Nevada, the company started doing business in 2017 and was established with a vision of becoming a nationally recognized concert production company. The company currently has more than 30,000 national followers and nearly 100 team members who have helped the company successfully organize some of the most exciting Electronic Dance Music concerts in Las Vegas.

Lavish Entertainment is currently doing business as EpicRaves, which will eventually become a wholly owned subsidiary of Lavish Entertainment as the company expands its business into a variety of other forms of entertainment. The company is currently building a unique virtual reality platform to help expand on its live events, and it is working to acquire a 68,000 sq. ft. event center with a vision to develop one of the most advanced event centers in the world.

Technology Division – HyFrontier Technology

HyFrontier Technologies is a wholly owned subsidiary of Golden Triangle Ventures under its Technology Division. The company owns a patent-pending process and device technology called HyGrO, which is a molecular hydrogen and oxygen delivery system for agriculture. Golden Triangle Ventures is assisting the company in commercializing the HyGrO unit for farm and home use in markets across the globe. HyFrontier Technologies has a mission to improve global crop production efficiency by producing hydrogen and oxygen directly in the water stream.

This technology can be used on any species of plant life in nearly any grow medium. Additionally, the system can be retrofitted to wellheads for large-scale agricultural projects, indoor grow operations and small farms or utilized for a multitude of residential home and garden applications. In-house testing has shown evidence that hydrogen is capable of increasing crop yields by up to 25% and, in many circumstances, a much higher amount. Larger root systems and better overall plant health were also observed by watering plants with the HyGrO unit. Universities and multiple third-party testing facilities are currently working to validate the HyGrO technology, and all preliminary results are extremely positive.

To push the development and commercialization of the technology, management is now in the process of moving the company headquarters from Colorado to Florida, which will transition its operations into a 7,800 sq. ft. state-of-the-art manufacturing facility. The company recently executed a three-year lease with an option to purchase the entire 24,000 sq. ft. building, which will help the business in achieving its ultimate goal of commercializing this technology to the world.

Food & Wine Division – Napa Wine Brands

Napa Wine Brands is a wholly owned subsidiary of Golden Triangle Ventures which is a synergistic business with a mission of providing a world-class portfolio of unique brands birthed from Napa Valley and Sonoma Valley in the heart of California’s Wine Country.

The company has a commitment to manufacture and distribute specialty wines, foods and unique items while tapping into an array of hidden markets in the food and beverage industry. With extensive resources and award-winning products, Napa Wine Brands aims to develop some of the most desirable products in today’s market. Originated by some of the most profound experts in Napa Valley, the company’s vision is to broaden the horizon of a traditional food and wine company by creating a platform different than anything seen in the Northern Hemisphere.

Napa Wine Brands has an array of fully developed products and services that provide value to the other divisions under Golden Triangle Ventures. The company is now preparing the launch of several brands, products and services that are market-ready and will immediately turn into cash-positive businesses. Golden Triangle Ventures will provide a full support system and assist management of Napa Wine Brands in growing this company into another fun, exciting and profitable division of Golden Triangle Ventures.

Recent Updates

  • On May 26, 2021, Golden Triangle announced its acquisition of The Lodge Winery & Olive Oil Co. under the company’s Napa Wine Brands subsidiary. The Lodge Winery & Olive Oil Co. is an established wine brand that produces award-winning wines, olive oils and wine vinegars. “Our marketing team is now ready to launch an in-depth program focused on driving our products into big box stores, smaller retail outlets, online platforms and many other avenues,” Steffan Dalsgaard, CEO of Golden Triangle, stated in a news release announcing the acquisition. “We are working directly with [Napa Wine Brands CEO] Arron [Johnson] and his team to grow their bulk inventory and launch all of these products for the world to enjoy.”
  • On May 20, 2021, Golden Triangle announced its entry into a letter of intent to acquire Sonder Fulfillment LLC, a leader in the industrial hemp and CBD space that is dedicated to driving forward the most powerful and efficacious cannabinoid products in the world. “Over the past two years, our operating partners have compiled a team of the best minds in the industrial hemp industry to create a totally vertical operation from seed to shelf,” Joshua Weaver, CEO of Sonder Fulfillment, stated in a news release announcing the LOI. “This acquisition by Golden Triangle Ventures will fully capitalize our operations and allow us to further expand our product lines and enter into new markets across the globe.”
  • On May 19, 2021, Golden Triangle announced the execution of a formal agreement with Robert “Bo” DuBose to purchase the remaining 49% of HyFrontier Technologies Inc., giving Golden Triangle 100% ownership of the technology company. “This acquisition has been something that Bo and I have been working towards for quite some time and we are both incredibly happy to have this executed,” Dalsgaard stated in a news release announcing the acquisition. “We knew that completing this agreement would show the world that we are both fully committed to our shareholders and the brilliant future of this revolutionary company.”
  • On May 12, 2021, Golden Triangle announced its acquisition of a top tier, professional sound system and formed a partnership with SuperKollider Sound LLC to provide a strategic benefit to the company’s entertainment division under Lavish Entertainment Inc. “We are very excited to acquire this unbelievable sound system,” Dalsgaard stated in a news release announcing the acquisition. “Hennessey Sound Design has always been one of my favorite systems on the market, and the team at SuperKollider Sound are true professionals in this space.”

Management Team

Steffan Dalsgaard is the Founder & Executive Chairman of Golden Triangle. He has a background in business development, with over a decade of experience representing and consulting with dozens of private and public companies. Mr. Dalsgaard consults with companies on all of their corporate objectives while providing a professional and corporate face to their organizations. He has built a strong reputation in the public relations industry and has a mission to work with emerging growth companies that are positioned to become significant businesses in their respective fields.

Robert DuBose is the company’s Chief Innovations Officer & Director and the CEO of HyFrontier Technologies Inc. Mr. DuBose is responsible for the success of the HyGrO product in the agricultural market. His experience in the design and production of hydrogen equipment goes back more than a decade, including PEMFC technologies since 2009 with his company, Aquafuel Inc. Mr. DuBose was raised in the farming and machine shop business, where he learned firsthand how much work and love goes into a successful crop, as well as how elements, which are out of the farmers control, can have adverse effects on finances. His belief that being able to deliver a solution to increase growth, yield, health, stamina of crops and profitability for farmers would be a win-win for all led him to create the HyGrO product.

Stuart Seim is the Chief Development Officer & Director of Golden Triangle. He began his career as an associate professor at the University of Manitoba in the field of outdoor and environmental education after receiving his master’s degree and completing advanced educational studies. Coming from a family with an extensive financial background, Mr. Seim became a stockbroker for major regional financial firm Robert W. Baird. In a short time, he became the Branch Manager for Baird in Minneapolis, Minnesota, while also serving as a Managing Director for Baird. During this time, Mr. Seim also served on the board of an industrial hearing company, which he helped to launch as a new company (The TK Group). Mr. Seim currently resides in Colorado, where he is an advisor to several organizations.

Golden Triangle Ventures Inc. (GTVH), closed Friday's trading session at $10.83, up 4.4359%, on 81,689 volume with 697 trades. The average volume for the last 3 months is 269,609 and the stock's 52-week low/high is $2.33999991/$20.0783996.

Recent News

Correlate Energy Corp. (OTCQB: CIPI)

The QualityStocks Daily Newsletter would like to spotlight Correlate Energy Corp. (OTCQB: CIPI).

Correlate Energy Corp. (OTCQB: CIPI) is a publicly-traded company strategically positioned to capitalize on America’s unstoppable trend toward decentralized energy generation.

The energy grid in the U.S. is insufficient for the booming clean energy trend, and current infrastructure is limiting green energy distribution. Constructing the needed infrastructure to address this demand imbalance will cost billions and be far too slow, positioning decentralized systems, like those on offer from Correlate, in a key position for heightened demand.

Correlate has identified several key economic drivers powering the decentralized energy trend, including:

  1. Real Cost Savings – Customer pays zero money down and gets an instant electrical price discount to current rates.
  2. Massive Project Investment Funding – The International Energy Agency estimates that over one billion dollars per day will be invested in solar energy in 2023.
  3. Consistent Long-Term Incentives – The Inflation Reduction Act is a game-changer, supercharging renewables with $1.2 trillion in tax credits for 10 years of market support.
  4. Robust Customer Demand – Wood Mackenzie expects the U.S. solar industry to nearly triple in size over the next five years.

Correlate’s team of multi-decade experts who have worked with renowned global brands are positioning the company to make the most of this opportunity while consolidating a fragmented industry. Collectively, the team has developed, financed and deployed over $2 billion in clean energy projects to date.

Three-Pronged Strategy

Correlate is leveraging a three-pronged strategy aimed at driving shareholder value:

  1. Sell – Correlate seeks to finance, develop and profitably sell localized clean energy solutions and microgrids to industrial, commercial and residential customers.
  2. Retain – Correlate plans to retain ownership of some of these energy systems and thereby realize ongoing, reliable cash flow.
  3. Acquire – Correlate seeks to acquire proven renewable energy companies in order to exponentially grow earnings per share for investors.

This strategy is enhanced by current investment trends. Clean energy earnings are being sought after by investors. In Q4 2022, the median EBITDA multiple for green energy companies was 12.3x, according to Finerva.

Market Outlook

Over the next decade and beyond, renewable energy growth is expected to come primarily via decentralized systems like those offered by Correlate.
The Inflation Reduction Act enacted in late August 2022 is likewise expected to drive growth for the company by providing new tax incentives that reduce costs for clients and/or elevate returns to investors.

Commercial buildings consume more than 35% of the generated electricity in the U.S. and are underperforming in energy efficiency at every level. These buildings waste energy, emit too much carbon and are too costly for owners and occupants, but retrofits are not happening at the rate or scale needed.

In today’s real estate market, portfolio property owners own most commercial buildings, yet most building efficiency work is focused on single buildings, thereby missing the distinct needs of this owner class which are very different from traditional owner-occupiers. The diverse nature of commercial buildings, combined with technology and performance uncertainty, make simple energy optimization initiatives – which could greatly reduce energy use and improve building value – financially unattractive, resulting in slow adoption rates. CIPI’s financial instruments and software breakdown this issue, known as the ‘split incentive’, unlocking the majority of the addressable market.

A key portion of Correlate’s strategy relates to consolidation of what has been a fragmented industry. By uncovering opportunities to improve efficiencies through strategic M&A activities, the company intends to enhance profitability throughout its operations.

Management Team

Todd Michaels is President and CEO of CIPI and founder of Correlate. He formerly served as Vice President for Innovation at SunEdison and Senior Director Distributed Solar at NRG Energy. He founded Correlate in 2015 and has 16 years of experience in the energy industry. He graduated from Indiana University with a B.S. in Computer Information Systems.

Channing Chen is CFO at CIPI and Correlate Inc. and brings over 16 years of experience in the solar industry as a developer, financier, and business unit leader. He has held executive management roles at Solar Power Partners (acquired by NRG Energy), where he was a founding employee, SunEdison, and NRG Energy (NYSE: NRG). Most recently, Mr. Chen was founder and Managing Partner at Breakaway Energy Partners LLC – a distributed energy financing and market-making platform. To date, Mr. Chen and his teams have raised over $1.5 billion in financing across residential, commercial, and utility scale solar and energy storage projects representing over 400 MWs. He holds a B.A. in Environmental Chemistry from the University of California at San Diego and an MBA from the University of Southern California. He is also an advisor and early-stage investor to several startup companies in the renewable energy space.

Dave Bailey is Chief Revenue Officer of Correlate Inc. With over 15 years of executive sales, supply chain management, and energy efficiency experience, he is responsible for ensuring the success of the National Commercial Sales Unit across multiple regional project teams. Mr. Bailey created and launched the Transformation Services team while at Wesco for its multibillion-dollar Distributed Energy Resource division, formerly Westinghouse. His focus was on IoT-enabled efficiency and plant floor automation-based services. Before that, he spent several years in Global Account Sales Management, with GE Supply as a Program Manager, and is a Commercial Leadership Program graduate. Mr. Bailey received his B.S. in Mechanical Engineering from the University of Kentucky.

Jed Freedlander is the company’s Chief Development Officer. He has a background in infrastructure development and investment and a strong legal, commercial and finance acumen. Mr. Freedlander has a proven track record in leading complex public-private partnership (P3) and energy transactions and is instrumental in driving Correlate’s strategic development initiatives.

Roger Baum is Executive VP Operations at Correlate. With over 20 years of experience at Core Construction, he brings to the company a wealth of knowledge and a strong track record in delivering successful commercial construction projects.

Jason Loyet is Director of Solar Energy for Correlate Inc. He is a cleantech executive with over 20 years of experience leading high growth solar energy and software start-ups. Mr. Loyet is a U.S. Department of Energy SunShot Catalyst award winner for his work building the Solar Site Design technology platform. Before joining the solar energy industry in 2005, he founded and sold two software companies in the streaming media (GlobalStreams) and newspaper publishing (MyCapture) industries. Mr. Loyet currently serves as a Member of the Board of Directors for the Tennessee Solar Energy Industry Association (TenneSEIA).

Correlate Energy Corp. (OTCQB: CIPI), closed Tuesday's trading session at $0.65, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.4121/$2.35.

Recent News

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF)

The QualityStocks Daily Newsletter would like to spotlight Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF).

Reflex Advanced Materials Corp. (CSE: RFLX) (OTCQB: RFLXF) is a strategic minerals company focused on locating and developing economic properties in the strategic metals and advanced materials space. The company aims to improve domestic specialty mineral infrastructure efficiencies to meet surging national demand from North American manufacturers, effectively positioning itself as one of the only North American suppliers of high purity natural graphite for hi-tech applications.

Reflex Advanced Materials is based in Vancouver, British Columbia. Its project portfolio includes the Ruby Graphite Deposit in Montana and the ZigZag Lithium Property in Ontario.

Projects

Ruby Graphite Project

Located in a mining-friendly jurisdiction in southwest Montana, the Ruby Graphite Deposit is a low cost, rapid re-entry opportunity that produced roughly 2,400 tons of graphite from 1902 to 1948. Reflex Advanced Materials holds mining rights for 755 hectares at the Ruby Graphite Project, with 96 federal lode mining claims. Recent samples assay at 95.8% to 98.4% total carbon.

The site is notable as the only combined U.S. graphite flake and vein graphite source. Vein graphite is ideal for energy storage applications, because it requires fewer steps to achieve purity than synthetic alternatives and is therefore far less environmentally damaging. This is expected to play a key role in the project’s development as demand for electric vehicles continues to surge.

In March 2023, the company announced its submittal of permit applications to the Bureau of Land Management in respect of its exploration of the Ruby Graphite Project. Its initial drill program, expected to take place in the summer of 2023, includes plans for 3,500 total meters of drilling, cored to an average depth of 130 meters. The targets for this drill program have been identified using historical data from original mine operations and data gathered for the initial 43-101 technical report on the project, dated January 31, 2023.

ZigZag Lithium Property

Located in the Thunder Bay Mining Division of Ontario, the ZigZag Lithium Property consists of eight mining claims spanning roughly 2,710 hectares. Mineralization at the property, most notably lithium, is based in pegmatite dikes and concentrated in spodumene crystals, which are consistent throughout the entire unit.

Spodumene is readily observable in outcrops and in drill cores, with crystal sizes ranging from 3-15cm, on average.

Reflex Advanced Materials and American Energy Technologies Company Metallurgical Partnership

Reflex Advanced Materials has entered into a material processing agreement with American Energy Technologies Co., which is based in Arlington Heights, Illinois, to conduct metallurgical testwork with the goal of creating a technical support data package for Reflex’s target customer base, U.S. Federal agencies and qualification programs with hi-tech customers in the battery and battery storage business.

The resulting coated, spherionized, purified graphite (CSPG) material that is expected to be created from the aforementioned tests will be used to provide potential customers of CSPG with samples so that they can begin the material qualification process.

Market Opportunity

Graphite is an ideal battery anode and has dominated the market since the proliferation of lithium-ion batteries. Despite this demand, there is currently no significant production of lithium-ion battery anode material in North America.

Instead, most graphite sold in North America today is sourced from Chinese producers. U.S. President Joe Biden highlighted this sourcing disparity in a 2022 address:

“The United Stated depends on unreliable foreign sources for many of the strategic and critical materials necessary for the clean energy transition – such as lithium, nickel, cobalt, graphite and manganese for large-capacity batteries,” he said. “Demand for such materials is projected to increase exponentially as the world transitions to a clean energy economy.”

The U.S. Department of Energy is in the process of awarding $2.8 billion to expand domestic manufacturing of batteries for electric vehicles and combat this foreign dependency. Reflex Advanced Materials has identified its Ruby Graphite Project as a prime candidate for U.S.-sponsored initiatives due to the rarity and scarcity of natural graphite deposits in the country.

Processing graphite domestically in the U.S. is expected to provide Reflex Advanced Materials a competitive advantage as manufacturers begin to seek out American supply in the face of increased diplomatic tension. This is critical, as a rise in anode demand is expected to fuel a shortage of 8 million tonnes of graphite by 2040. World Bank Group projects 494% growth in total graphite demand by 2050.

Leadership Team

Paul Gorman is the CEO and a Director of Reflex Advanced Materials. He brings to the company over 25 years of experience in junior mining finance, public listings, viability assessment and operational rationalization. For 18 years, Mr. Gorman served as president and managing partner of Riverbank Capital, where he played an instrumental role in raising more than $85 million for small-cap companies. In 2008, he funded Industrial Minerals Inc. (later Northern Graphite) and served in an advisory role for four other graphite companies, contributing significantly to the revitalization of the junior graphite space in North America. Mr. Gorman founded Mega Graphite Inc. in 2009 and has served as chief executive for three other companies.

Tasheel Jeerh, CPA, is the company’s CFO. He is a finance and accounting professional with over a decade of experience spanning both public and private sectors. Prior to joining Reflex Advanced Materials, Mr. Jeerh played a pivotal role in the growth of a private upstream oil and gas firm, dealing with over $2 billion in M&A activity and $1 billion in financing activities. He gained his designation at PricewaterhouseCoopers, where he worked as a manager in the assurance practice.

Greg Bell is Project Manager for Reflex Advanced Materials. He is a multi-disciplined engineering management professional with more than 40 years of experience in the natural resources sector. Mr. Bell has successfully built and managed several start-up operations in various capacities. He has been active in graphite and lithium exploration for the past seven years.

Christopher W. Hill leads the company’s Corporate Development initiatives. He is an investor and entrepreneur with over a decade of experience in the capital markets. Mr. Hill began his career as an investment advisor and then began to consult and advise private companies on their paths to becoming publicly traded. He specializes in corporate development and strategic financing utilizing his large network in the capital markets.

Reflex Advanced Materials Corp. (RFLXF), closed Tuesday's trading session at $0.053, up 32.5%, on 10,100 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0306/$0.35.

Recent News

ECGI Holdings Inc. (OTC: ECGI)

The QualityStocks Daily Newsletter would like to spotlight ECGI Holdings Inc. (OTC: ECGI).

ECGI Holdings Inc. (OTC: ECGI) is a diversified holding company with a distinctive portfolio encompassing viticulture and luxury fashion. The company owns and manages a five-acre vineyard in Lake County, California, specializing in cultivating the Petite Sirah varietal, known for its bold and rich character, aligning with the growing demand for unique and high-quality wine experiences.

In the fashion sector, ECGI has strategically invested in Pacific Saddlery, a premier manufacturer and retailer of luxury equestrian tack, apparel and accessories. This unique blend of wine and fashion investments reflects ECGI Holdings’ commitment to delivering sophistication and innovation across diverse markets, positioning the company as a distinctive player in the intersection of technology, viticulture and luxury lifestyle.

Moving forward, ECGI Holdings is focused on identifying and capitalizing on growth opportunities that align with the company’s business objectives and continuing to improve its financial structure. In 2024, ECGI Holdings was approved by Evolve — a distinguished name in vacation rental management. This partnership will transform the company’s 40-acre Lake County property into a luxurious short-term rental destination aptly named Vintner’s Caldera Ranch.

ECGI Holdings is excited about the possibilities that Vintner’s Caldera Ranch creates for shareholders and looks forward to further developments poised to unlock the value of other underutilized assets. The company believes that it is laying a solid foundation for sustained success and profitability in the years to come.

ECGI Holdings is headquartered in Irvine, California.

Operational Philosophy

ECGI Holdings has embarked on an ambitious new vision and strategic direction to build and nurture luxury brands that resonate with its core values and market aspirations. Its joint venture with Pacific Saddlery epitomizes ECGI Holdings’ strategic shift toward luxury branding, leveraging Pacific Saddlery’s tangible and established market presence in equestrian products.

This transition will also allow ECGI Holdings to explore new pathways to monetize its underutilized assets, including the company’s vineyard. A key highlight of the company’s future outlook is the debut of Pacific Saddlery’s new mobile retail boutique at specific equestrian events in 2024. This innovative venture represents a significant step in ECGI Holdings’ strategy to enhance brand visibility and engage directly with the company’s target market.

In addition, the Vintner’s Caldera Ranch development marks a significant step in advancing the company’s strategy to revitalize and leverage underutilized assets. Vintner’s Caldera Ranch is set against the backdrop of Lake County’s breathtaking scenery, offering an exclusive getaway experience that blends natural beauty with luxury. Choosing Evolve is a strategic move to ensure that Vintner’s Caldera Ranch not only meets but exceeds the high standards of service that luxury guests expect.

Evolve’s expertise in maximizing rental potential and delivering exceptional guest experiences is crucial to the company’s vision of making Vintner’s Caldera Ranch a preferred choice for discerning travelers. With this venture, ECGI Holdings is not only expanding its footprint within the luxury rental marketplace, but also contributing to the local economy and enhancing the appeal of Lake County as a tourist destination.

The company’s focus remains steadfast on strategic growth, operational excellence and customer satisfaction.

Market Outlook

A report from Grand View Research, a global market research and consulting company, estimated the value of the worldwide luxury brands market at $366.23 billion in 2023 and projects the market to grow to a value of $580.43 billion by 2030, achieving a CAGR of 6.8% over the forecast period.

Rising disposable income and wealth in various regions of the world, particularly in emerging markets such as China and India, have propelled the growth of the market, according to the report.

Younger consumers, such as millennials and Generation Z, are increasingly entering the luxury market, driving demand for more contemporary and experiential luxury offerings. The rise of social media and influencer marketing has greatly impacted the visibility and desirability of luxury products, the report states.

Management Team

Jamie Steigerwald is CEO of ECGI Holdings, Inc. He is a successful entrepreneur with over 30 years of experience. Most recently, he was COO of Sugarmade Inc. (OTC: SGMD), a California cannabis real estate, cultivation, manufacturing and services company. He is the owner of SwiftLead, an Orange County web marketing, design and development company. He previously was COO for First USA Home Loans, a retail mortgage lender, and co-founder and President of SwiftLead Software, a mortgage lead tracking system.

Nick Collins is CEO at Pacific Saddlery. He brings over 25 years of expertise in equestrian luxury goods. He previously founded Rolling Meadows and created the Allon Equestrian and Renard et Cheval apparel brands. He was instrumental in creating and launching Kaval.com, an online equestrian apparel and accessories site.

ECGI Holdings Inc. (OTC: ECGI), closed Tuesday's trading session at $0.0031, even for the day, on 5 volume. The average volume for the last 3 months is 715,209 and the stock's 52-week low/high is $0.0016/$0.018.

Recent News

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF)

The QualityStocks Daily Newsletter would like to spotlight FuelPositive Corp. (NHHHF).

FuelPositive Corp. (TSX.V: NHHH) (OTC: NHHHF) is a growth stage company focused on licensing, partnership and acquisition opportunities building upon various technological achievements. The company is committed to providing commercially viable and sustainable clean energy solutions, including carbon-free ammonia (NH3), for use across a broad spectrum of industries and applications.

FuelPositive is headquartered in Toronto, Canada.

Hydrogen Economy Problems and FuelPositive’s Carbon-Free Technology

The hydrogen economy is currently facing many challenges. Traditional NH3 manufacturing exists on a massive scale, but centralized facilities result in some of the world’s most concentrated CO2 emissions. In total, an estimated 200 million metric tonnes of NH3 are consumed each year, with greater than 80% utilized by the agricultural sector. NH3 is also being positioned as a viable alternative to fossil fuels.

FuelPositive’s flagship carbon-free ammonia technology provides an innovative solution to these environmental concerns. Developed by Dr. Ibrahim Dincer and his team, the company’s platform allows for the in-situ production of NH3 in an entirely sustainable manner, using only water, air and sustainable electricity.

The production of hydrogen is energy intensive, but it is just one variable hindering the growth of the hydrogen economy. Other hurdles include:

  • Storage – The storage of hydrogen by compression or liquification are both cost prohibitive and unsustainable.
  • Distribution – The distribution network for effective hydrogen deployment has yet to be developed, as the extreme high-pressure distribution requirements to transport hydrogen would result in enormous infrastructure costs.
  • End Use – R&D on the transportation-related end use applications for hydrogen is in its infancy, but almost any vehicle on the road today can be easily converted to run on NH3 at a considerably lower cost per mile traveled when compared to traditional fossil fuels.

A key benefit of FuelPositive’s patent-pending, first-of-its-kind carbon-free NH3 technology is its flexibility. The process allows for small, medium or large-scale production of NH3 on location, minimizing or even eliminating the challenges and volatility associated with storage and transportation to end use. As such, with an appropriately sized FuelPositive system and access to renewable energy, the end use applications for the company’s platform are nearly infinite.

Manufacturing Partnership

On May 19, 2021, FuelPositive announced its selection of National Compressed Air Canada Ltd. (“NCA”) to undertake manufacturing of the company’s Phase 2 hydrogen-ammonia synthesizer commercial prototype systems for carbon-free ammonia production.

In a news release detailing the partnership, FuelPositive CEO Ian Clifford noted, “This critical milestone for FuelPositive will confirm the broad application potential for our technology and is the backbone of our Carbon-Free Hydrogen-NH3 offering. Partnering with the knowledgeable and experienced team at NCA on this commercialization project will bring our development-stage program to life.”

Global Ammonia Market Outlook

The global ammonia market was valued at $52.71 billion in 2017 and is forecast to reach $81.42 billion by 2025, growing at a CAGR of 5.59%, according to data from Fior Markets (https://ibn.fm/1OfOB).

The agricultural industry consumes more than 80% of global NH3. Smaller percentages can be attributed to the waste, water treatment, refrigerants, antiseptic, textile, mining and pharmaceutical industries.

One of the most polluting industries on the planet consists of conventional agribusinesses. These polluters are responsible for more greenhouse emissions per year than transportation. This is where FuelPositive’s technology is expected to be extremely beneficial.

Management Team

Ian Clifford is Director, CEO and Founder of FuelPositive Corp. He has over 25 years of experience in the fields of technology and marketing and has successfully led the company to global brand recognition through its unique energy solutions. Since 2006, Mr. Clifford has raised over $50 million in equity financing for FuelPositive. He also co-founded digIT Interactive, a full-service internet marketing company serving Fortune 500 clients, which he sold at the peak of the market in 2000.

Greg Gooch serves as a Director and President of FuelPositive. His multifaceted career in the electronics and finance industries has positioned him as a key advisor and funding partner to start-ups and new technology companies for over 40 years. Mr. Gooch has been involved with FuelPositive since its early days and has remained a significant supporter and consultant to the company over the years. He has a bachelor’s from McGill University and an MBA from the University of Western Ontario.

Dr. Ibrahim Dincer is a scientific advisor to FuelPositive and is recognized as a pioneer and international leader in the area of sustainable energy technologies. Along with his team, Dr. Dincer invented the modular carbon-free ammonia (NH3) production technology that FuelPositive is commercializing. His area of specialty covers various topics including ammonia, hydrogen energy and fuel cells; renewable energy systems; energy storage systems and applications; carbon capturing technologies, and integrated and hybrid energy systems He is currently managing an exemplary team of researchers in this commercialization project.

Marek Warunkiewicz is the company’s Communications & Branding Specialist. He brings more than 40 years of entrepreneurial expertise to the FuelPositive team, having held marketing, branding, advertising, project management and graphic design positions with various companies. Mr. Warunkiewicz has successfully created business-to-business marketing and advertising campaigns for a diverse group of clients ranging from high-tech to agriculture. He co-founded digIT Interactive and ZENN Motor Company alongside Ian Clifford.

Luna Clifford is the Director of Communications for FuelPositive. She has over 10 years of experience as a business owner and advisor, helping build and operate several successful start-up enterprises while managing complex stakeholder relationships. Ms. Clifford excels in strategic planning and team building, and she has completed extensive studies in the fields of communications and health care.

FuelPositive Corp. (NHHHF), closed Tuesday's trading session at $0.0452, up 16.4948%, on 167,100 volume. The average volume for the last 3 months is 523,419 and the stock's 52-week low/high is $0.03/$0.07.

Recent News

HeartBeam Inc. (NASDAQ: BEAT)

The QualityStocks Daily Newsletter would like to spotlight HeartBeam Inc. (NASDAQ: BEAT) .

HeartBeam Inc. (NASDAQ: BEAT) is a cardiac technology company that has developed the first and only 3D-vector 12-lead electrocardiogram (ECG) platform for heart attack detection anytime, anywhere. The company’s proprietary ECG telehealth technology aims to redefine the way high risk cardiovascular patients are diagnosed in ambulatory and acute care settings. HeartBeam’s initial focus is on providing diagnostic data to help physicians with care management of patients with cardiovascular disease.

In August 2022, HeartBeam announced that it submitted its HeartBeam AIMI™ software for approval from the U.S. Food and Drug Administration (FDA). HeartBeam AIMI is a platform technology to improve the speed and accuracy of heart attack detection in acute care settings. The company expects FDA approval by the end of 2022, and a full commercial roll-out of HeartBeam AIMI is targeted for Q1 2023.

HeartBeam sees submission of its first product based on its platform technology as an important milestone toward commercialization, which underscores the company’s continued progress toward making the HeartBeam AIMI platform widely available to help emergency department physicians quickly and accurately identify a heart attack.

While the FDA conducts its regulatory review, HeartBeam will focus on executing key components of its commercialization plan and subscription revenue model. It will also continue to engage in discussions with strategic institutions, including academic centers, regional healthcare systems and regional community hospital systems that can utilize HeartBeam products.

The company is based in Santa Clara, California.

Products

HeartBeam’s development portfolio includes two products:

  • HeartBeam AIMI is software that provides a 3D comparison of baseline and symptomatic 12-lead ECG to more accurately identify a heart attack in acute care settings and, as noted above, has been submitted for FDA approval; and
  • HeartBeam AIMIGo™, the first and only credit card-sized 12-lead output ECG device coupled with a smartphone app and cloud-based diagnostic software system for remote heart attack detection.

HeartBeam is developing AIMIGo, a medical-grade detection and monitoring technology for use in remote heart attack detection, thereby allowing physicians to diagnose a patient’s heart attack as it occurs, even if the patient is not at a medical facility. The company’s system, once approved by the FDA, can be used by patients at home or almost anywhere and anytime to help their physicians assess whether chest pain is the result of a heart attack or another cause. While approximately 82% of chest pain ED visits are unnecessary, patients delay approximately 3 to 4 hours after symptoms begin, increasing mortality rates by 40%. The company’s goal is to shorten the time to treatment outside of the medical facility to improve patients’ well-being.

HeartBeam’s AIMIGo is a powerful, portable and easy-to-use prescription-based product. It comprises a smartphone app, a credit card-sized ECG device placed on a patient’s chest, the HeartBeam cloud platform, and a digital portal for the physician to view ECG results and direct patient action. For the first time outside of a medical setting, HeartBeam AIMIGo enables patients and their clinicians to determine if symptoms are due to a heart attack, quickly and easily, so care can be expedited, if needed.

Pending FDA clearance, AIMIGo is initially intended to be available by prescription, and is reimbursable under existing remote patient monitoring codes (RPM codes). This provides a new revenue stream to physicians who before did not have a way to monitor these high-risk patients. The RPM codes provide a monthly reoccurring revenue stream to the company, as well. On average, at current reimbursement rates, the practice will receive $1,300+ per year per patient they monitor, and the company will receive $600 per year per patient from this RPM reimbursement.

Market Overview

Adoption rates of telehealth services increased dramatically in recent years, with the COVID-19 pandemic serving as a major driver of growth. Among the areas seeing the greatest expansion are cardiology, radiology, behavioral health and online consultation.

Encouraging this growth, governments are actively developing new policies and reimbursement guidelines to promote the use of digital health platforms. The U.S. Centers for Medicare & Medicaid Services (CMS), for example, has recently expanded reimbursement for telehealth services. U.S. market growth is also being driven by the rising prevalence of chronic conditions and the growing geriatric population.

Remote heart attack detection is a previously unsolved problem with a massive and underserved market that is several times larger than the $2 billion total addressable market (TAM) in the U.S. for ECG cardiac arrhythmia monitoring.

Approximately 8 million Americans have suffered at least one heart attack, and a total of 18 million have been diagnosed with coronary artery disease (CAD). Based on these figures, HeartBeam projects a total addressable U.S. market TAM valued at $10 billion annually for its AIMIGo solution for remote heart attack monitoring of CAD.

Management Team

Branislav Vajdic, Ph.D., Chief Executive Officer and Founder of HeartBeam, Inc, combines over 30 years of experience in technology development and senior management positions. Dr. Vajdic has been deeply involved with the development of HeartBeam’s technology to fit his vision for the company. Prior to HeartBeam, from 2007 to 2010, Dr. Vajdic was CEO and Founder of NewCardio, a publicly traded company in the cardiovascular devices space. From 1984 to 2007, Dr. Vajdic was at Intel, where he held various senior management position. At Intel, Dr. Vajdic was the designer of first Flash memory and two key inventions that enabled Flash as a product and led engineering groups responsible for Pentium 1 through Pentium 4 designs. Dr. Vajdic was awarded two Intel Achievement Awards, the highest level of award for outstanding contributions to Intel. Dr. Vajdic is author of numerous patents and publications in the fields of cardiovascular devices, as well as chip design. Dr. Vajdic holds a Ph.D. in Electrical Engineering from the University of Minnesota.

Jon Hunt, Ph.D., has over 35 years’ experience in the medical/medical device industry with extensive domestic and international experience in general management, clinical/regulatory, sales and marketing. He also has diverse experience in Fortune 500 companies, as well as start-up environments. Dr. Hunt was the Vice President of Clinical Science and Technology, Medical Device Innovation Consortium, from July 2019 to July 2021, and Vice President of Clinical and Regulatory Affairs, Cryterion Medical from January 2018 to June 2019 (acquired by Boston Scientific Corporation in July 2018 for $202M). Dr. Hunt was the Founding President and CEO of Bardy Diagnostics, Inc. from October 2013 to November 2017 (acquired by Hill-Rom Holdings, Inc.). Prior to joining Bardy Diagnostics, Dr. Hunt spent the previous 11 years as the Vice President of Clinical & Regulatory Affairs with Cameron Health, Inc. (acquired by Boston Scientific Corporation). Dr. Hunt spent the previous 10 years with Cardiac Pacemakers, Inc., St. Jude Medical and Cardiac Pathways Corporation. Dr. Hunt began his career with Cardiac Pacemakers, Inc. (now Boston Scientific Corporation) as the Director of Clinical Programs. He subsequently held positions at St. Jude Medical in Clinical Affairs and as the Business Unit Director for the Cardiac Rhythm Management division for Europe, the Middle East and Africa. At Cardiac Pathways Corporation, Dr. Hunt held various executive positions as Vice President of International Sales and Marketing and Vice President of Worldwide Sales and Marketing (acquired by Boston Scientific Corporation). Dr. Hunt received his Ph.D. in Motor Control from The Pennsylvania State University, his Master’s from California State University, Long Beach and his undergraduate degree from Keele University in the United Kingdom.

Rick Brounstein, HeartBeam’s Chief Financial Officer, combines over 30 years of experience in health technology senior management. Since 2017, Mr. Brounstein has been and is currently a partner of Hardesty, LLC, a financial services firm, and Mr. Brounstein is currently a managing director of CTRLCFO, LLC, a firm Mr. Brounstein founded in 2016 to support funded start-ups in life science and technology. From 2008 to 2011, Mr. Brounstein was Chief Financial Officer of NewCardio, Inc., a microcap public company in the cardiology space, and, over his career, he has been with nine other companies in life science or technology, holding positions including Chief Financial Officer, Chief Operating Officer, Treasurer and Accounting Manager. From June 2001 through November 2007, Mr. Brounstein held several positions at Calypte Biomedical Corporation, a publicly traded medical device company, including Chief Financial Officer and Executive Vice President. In January 2007, Mr. Brounstein was appointed as the National Member Representative for the 2007 COSO Monitoring Project, which published new guidelines for monitoring internal financial controls in February 2009; Mr. Brounstein subsequently was a member of the FEI task force that issued the updated COSO Internal Control Framework in 2013. In March 2005, Mr. Brounstein was appointed to the SEC Advisory Committee on Smaller Public Companies. Mr. Brounstein earned his Certified Public Accountant (CPA) certification while working at Arthur Andersen LLP, formerly a public accounting firm. Mr. Brounstein holds a B.A. in accounting and an M.B.A. in finance, both from Michigan State University.

Ken Persen, HeartBeam’s Chief Technology Officer, combines over 28 years of experience in the medical device and digital health industries in engineering and senior management positions. Mr. Persen has been involved in several companies in Cardiac Rhythm Management, holding positions including Chief Executive Officer, Chief Technology Officer, Executive Vice President and Director of Engineering. Since 2016 and prior to joining HeartBeam, Mr. Persen was the Chief Technology Officer at LIVMOR, Inc., a digital health company. In addition, from 2016 through November 2021, he was also Chief Executive Officer of LIVMOR. Prior roles included Director of Engineering at Cameron Health (acquired by Boston Scientific), a late-stage medical device start up, and engineering and management positions at Guidant Corp. (acquired by Boston Scientific), a large medical device manufacturer. He has an undergraduate degree from University of Minnesota, Duluth, with a BA in Computer Science.

HeartBeam Inc. (NASDAQ: BEAT), closed Tuesday's trading session at $2.95, up 18.9516%, on 555,567 volume. The average volume for the last 3 months is 112,850 and the stock's 52-week low/high is $1.06/$3.74.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPRMissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.